Billy R. Martin - Publications

Affiliations: 
Virginia Commonwealth University, Richmond, VA, United States 
Area:
Behavioral Pharmacology of Cannabinoids

269/500 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Wiley JL, Smith VJ, Chen J, Martin BR, Huffman JW. Synthesis and pharmacology of 1-alkyl-3-(1-naphthoyl)indoles: steric and electronic effects of 4- and 8-halogenated naphthoyl substituents. Bioorganic & Medicinal Chemistry. 20: 2067-81. PMID 22341572 DOI: 10.1016/J.Bmc.2012.01.038  0.609
2012 Wiley JL, Marusich JA, Martin BR, Huffman JW. 1-Pentyl-3-phenylacetylindoles and JWH-018 share in vivo cannabinoid profiles in mice. Drug and Alcohol Dependence. 123: 148-53. PMID 22127210 DOI: 10.1016/J.Drugalcdep.2011.11.001  0.583
2011 Wiley JL, Breivogel CS, Mahadevan A, Pertwee RG, Cascio MG, Bolognini D, Huffman JW, Walentiny DM, Vann RE, Razdan RK, Martin BR. Structural and pharmacological analysis of O-2050, a putative neutral cannabinoid CB(1) receptor antagonist. European Journal of Pharmacology. 651: 96-105. PMID 21114999 DOI: 10.1016/J.Ejphar.2010.10.085  0.814
2010 Huffman JW, Hepburn SA, Lyutenko N, Thompson AL, Wiley JL, Selley DE, Martin BR. 1-Bromo-3-(1',1'-dimethylalkyl)-1-deoxy-Δ(8)-tetrahydrocannabinols: New selective ligands for the cannabinoid CB(2) receptor. Bioorganic & Medicinal Chemistry. 18: 7809-15. PMID 20943404 DOI: 10.1016/J.Bmc.2010.09.061  0.592
2010 Huffman JW, Hepburn SA, Reggio PH, Hurst DP, Wiley JL, Martin BR. Synthesis and pharmacology of 1-methoxy analogs of CP-47,497. Bioorganic & Medicinal Chemistry. 18: 5475-82. PMID 20621488 DOI: 10.1016/J.Bmc.2010.06.054  0.604
2010 Carroll FI, Ma W, Deng L, Navarro HA, Damaj MI, Martin BR. Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 3'-(substituted phenyl)epibatidine analogues. Nicotinic partial agonists. Journal of Natural Products. 73: 306-12. PMID 20038125 DOI: 10.1021/Np9006124  0.398
2009 Vann RE, Warner JA, Bushell K, Huffman JW, Martin BR, Wiley JL. Discriminative stimulus properties of delta9-tetrahydrocannabinol (THC) in C57Bl/6J mice. European Journal of Pharmacology. 615: 102-7. PMID 19470387 DOI: 10.1016/J.Ejphar.2009.05.010  0.585
2008 Merritt LL, Martin BR, Walters C, Lichtman AH, Damaj MI. The endogenous cannabinoid system modulates nicotine reward and dependence. The Journal of Pharmacology and Experimental Therapeutics. 326: 483-92. PMID 18451315 DOI: 10.1124/Jpet.108.138321  0.671
2008 Vann RE, Gamage TF, Warner JA, Marshall EM, Taylor NL, Martin BR, Wiley JL. Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Delta(9)-tetrahydrocannabinol. Drug and Alcohol Dependence. 94: 191-8. PMID 18206320 DOI: 10.1016/J.Drugalcdep.2007.11.017  0.78
2008 McKinney DL, Cassidy MP, Collier LM, Martin BR, Wiley JL, Selley DE, Sim-Selley LJ. Dose-related differences in the regional pattern of cannabinoid receptor adaptation and in vivo tolerance development to delta9-tetrahydrocannabinol. The Journal of Pharmacology and Experimental Therapeutics. 324: 664-73. PMID 17967938 DOI: 10.1124/Jpet.107.130328  0.635
2008 Ivy Carroll F, Yokota Y, Ma W, Lee JR, Brieaddy LE, Burgess JP, Navarro HA, Damaj MI, Martin BR. Synthesis, nicotinic acetylcholine receptor binding, and pharmacological properties of 3'-(substituted phenyl)deschloroepibatidine analogs. Bioorganic & Medicinal Chemistry. 16: 746-54. PMID 17964169 DOI: 10.1016/J.Bmc.2007.10.027  0.397
2008 Huffman JW, Thompson AL, Wiley JL, Martin BR. Synthesis and pharmacology of 1-deoxy analogs of CP-47,497 and CP-55,940. Bioorganic & Medicinal Chemistry. 16: 322-35. PMID 17919913 DOI: 10.1016/J.Bmc.2007.09.033  0.602
2007 Carroll FI, Robinson TP, Brieaddy LE, Atkinson RN, Mascarella SW, Damaj MI, Martin BR, Navarro HA. Synthesis and nicotinic acetylcholine receptor binding properties of bridged and fused ring analogues of epibatidine. Journal of Medicinal Chemistry. 50: 6383-91. PMID 17994682 DOI: 10.1021/Jm0704696  0.339
2007 Bourne C, Roy S, Wiley JL, Martin BR, Thomas BF, Mahadevan A, Razdan RK. Novel, potent THC/anandamide (hybrid) analogs. Bioorganic & Medicinal Chemistry. 15: 7850-64. PMID 17827022 DOI: 10.1016/J.Bmc.2007.08.039  0.517
2007 Gehani NC, Nalwalk JW, Razdan RK, Martin BR, Sun X, Wentland M, Abood ME, Hough LB. Significance of cannabinoid CB1 receptors in improgan antinociception. The Journal of Pain : Official Journal of the American Pain Society. 8: 850-60. PMID 17644043 DOI: 10.1016/J.Jpain.2007.05.015  0.439
2007 Niyuhire F, Varvel SA, Martin BR, Lichtman AH. Exposure to marijuana smoke impairs memory retrieval in mice. The Journal of Pharmacology and Experimental Therapeutics. 322: 1067-75. PMID 17586723 DOI: 10.1124/Jpet.107.119594  0.777
2007 Varvel SA, Martin BR, Lichtman AH. Lack of behavioral sensitization after repeated exposure to THC in mice and comparison to methamphetamine. Psychopharmacology. 193: 511-9. PMID 17497137 DOI: 10.1007/S00213-007-0811-2  0.774
2007 Naidu PS, Varvel SA, Ahn K, Cravatt BF, Martin BR, Lichtman AH. Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality. Psychopharmacology. 192: 61-70. PMID 17279376 DOI: 10.1007/S00213-006-0689-4  0.782
2007 Crocker PJ, Mahadevan A, Wiley JL, Martin BR, Razdan RK. The role of fluorine substitution in the structure-activity relationships (SAR) of classical cannabinoids. Bioorganic & Medicinal Chemistry Letters. 17: 1504-7. PMID 17257842 DOI: 10.1016/J.Bmcl.2007.01.006  0.565
2007 Pertwee RG, Thomas A, Stevenson LA, Ross RA, Varvel SA, Lichtman AH, Martin BR, Razdan RK. The psychoactive plant cannabinoid, Delta9-tetrahydrocannabinol, is antagonized by Delta8- and Delta9-tetrahydrocannabivarin in mice in vivo. British Journal of Pharmacology. 150: 586-94. PMID 17245367 DOI: 10.1038/Sj.Bjp.0707124  0.768
2007 Wise LE, Shelton CC, Cravatt BF, Martin BR, Lichtman AH. Assessment of anandamide's pharmacological effects in mice deficient of both fatty acid amide hydrolase and cannabinoid CB1 receptors. European Journal of Pharmacology. 557: 44-8. PMID 17217945 DOI: 10.1016/J.Ejphar.2006.11.002  0.794
2007 Vann RE, Cook CD, Martin BR, Wiley JL. Cannabimimetic properties of ajulemic acid. The Journal of Pharmacology and Experimental Therapeutics. 320: 678-86. PMID 17105826 DOI: 10.1124/Jpet.106.111625  0.657
2007 Ivy Carroll F, Ma W, Navarro HA, Abraham P, Wolckenhauer SA, Damaj MI, Martin BR. Synthesis, nicotinic acetylcholine receptor binding, antinociceptive and seizure properties of methyllycaconitine analogs. Bioorganic & Medicinal Chemistry. 15: 678-85. PMID 17098430 DOI: 10.1016/J.Bmc.2006.10.061  0.34
2007 Samudre S, Lattanzio FA, Martin BR, Castillo I, Hosseini A, Frazier M, Williams PB. Ocular Pharmacokinetics and Pharmacodynamics of Synthetic Cannabinoid, O‐1812, in a Perfused Rat Eye Model The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A417-C  0.493
2006 Wiley JL, Razdan RK, Martin BR. Evaluation of the role of the arachidonic acid cascade in anandamide's in vivo effects in mice. Life Sciences. 80: 24-35. PMID 16978656 DOI: 10.1016/J.Lfs.2006.08.017  0.573
2006 Wilson DM, Varvel SA, Harloe JP, Martin BR, Lichtman AH. SR 141716 (Rimonabant) precipitates withdrawal in marijuana-dependent mice. Pharmacology, Biochemistry, and Behavior. 85: 105-13. PMID 16934319 DOI: 10.1016/J.Pbb.2006.07.018  0.795
2006 Huffman JW, Padgett LW, Isherwood ML, Wiley JL, Martin BR. 1-Alkyl-2-aryl-4-(1-naphthoyl)pyrroles: new high affinity ligands for the cannabinoid CB1 and CB2 receptors. Bioorganic & Medicinal Chemistry Letters. 16: 5432-5. PMID 16889960 DOI: 10.1016/J.Bmcl.2006.07.051  0.596
2006 Sim-Selley LJ, Schechter NS, Rorrer WK, Dalton GD, Hernandez J, Martin BR, Selley DE. Prolonged recovery rate of CB1 receptor adaptation after cessation of long-term cannabinoid administration. Molecular Pharmacology. 70: 986-96. PMID 16760363 DOI: 10.1124/Mol.105.019612  0.396
2006 Martin BR, Wiley JL, Beletskaya I, Sim-Selley LJ, Smith FL, Dewey WL, Cottney J, Adams J, Baker J, Hill D, Saha B, Zerkowski J, Mahadevan A, Razdan RK. Pharmacological characterization of novel water-soluble cannabinoids. The Journal of Pharmacology and Experimental Therapeutics. 318: 1230-9. PMID 16757541 DOI: 10.1124/Jpet.106.104109  0.638
2006 Carroll FI, Hu X, Navarro HA, Deschamps J, Abdrakhmanova GR, Damaj MI, Martin BR. Synthesis and pharmacological characterization of nicotinic acetylcholine receptor properties of (+)- and (-)-pyrido-[3,4-b]homotropanes. Journal of Medicinal Chemistry. 49: 3244-50. PMID 16722642 DOI: 10.1021/Jm060122N  0.375
2006 Varvel SA, Wiley JL, Yang R, Bridgen DT, Long K, Lichtman AH, Martin BR. Interactions between THC and cannabidiol in mouse models of cannabinoid activity. Psychopharmacology. 186: 226-34. PMID 16572263 DOI: 10.1007/S00213-006-0356-9  0.805
2006 Abdrakhmanova GR, Damaj MI, Carroll FI, Martin BR. 2-Fluoro-3-(4-nitro-phenyl)deschloroepibatidine is a novel potent competitive antagonist of human neuronal alpha4beta2 nAChRs. Molecular Pharmacology. 69: 1945-52. PMID 16505153 DOI: 10.1124/Mol.105.021782  0.357
2006 Blair RE, Deshpande LS, Sombati S, Falenski KW, Martin BR, DeLorenzo RJ. Activation of the cannabinoid type-1 receptor mediates the anticonvulsant properties of cannabinoids in the hippocampal neuronal culture models of acquired epilepsy and status epilepticus. The Journal of Pharmacology and Experimental Therapeutics. 317: 1072-8. PMID 16469864 DOI: 10.1124/Jpet.105.100354  0.371
2006 Bisogno T, Cascio MG, Saha B, Mahadevan A, Urbani P, Minassi A, Appendino G, Saturnino C, Martin B, Razdan R, Di Marzo V. Development of the first potent and specific inhibitors of endocannabinoid biosynthesis Biochimica Et Biophysica Acta - Molecular and Cell Biology of Lipids. 1761: 205-212. PMID 16466961 DOI: 10.1016/J.Bbalip.2005.12.009  0.313
2006 Grabus SD, Martin BR, Brown SE, Damaj MI. Nicotine place preference in the mouse: influences of prior handling, dose and strain and attenuation by nicotinic receptor antagonists. Psychopharmacology. 184: 456-63. PMID 16463055 DOI: 10.1007/S00213-006-0305-7  0.369
2006 Marriott KS, Huffman JW, Wiley JL, Martin BR. Synthesis and pharmacology of 11-nor-1-methoxy-9-hydroxyhexahydrocannabinols and 11-nor-1-deoxy-9-hydroxyhexahydrocannabinols: new selective ligands for the cannabinoid CB2 receptor. Bioorganic & Medicinal Chemistry. 14: 2386-97. PMID 16321538 DOI: 10.1016/J.Bmc.2005.11.023  0.586
2006 Ligresti A, Cascio MG, Pryce G, Kulasegram S, Beletskaya I, De Petrocellis L, Saha B, Mahadevan A, Visintin C, Wiley JL, Baker D, Martin BR, Razdan RK, Di Marzo V. New potent and selective inhibitors of anandamide reuptake with antispastic activity in a mouse model of multiple sclerosis. British Journal of Pharmacology. 147: 83-91. PMID 16284631 DOI: 10.1038/Sj.Bjp.0706418  0.548
2006 Huffman JW, Bushell SM, Joshi SN, Wiley JL, Martin BR. Enantioselective synthesis of 1-methoxy- and 1-deoxy-2'-methyl-delta8-tetrahydrocannabinols: new selective ligands for the CB2 receptor. Bioorganic & Medicinal Chemistry. 14: 247-62. PMID 16165365 DOI: 10.1016/J.Bmc.2005.08.013  0.601
2006 Lichtman AH, Martin BR. Understanding the pharmacology and physiology of cannabis dependence Cannabis Dependence: Its Nature, Consequences, and Treatment. 37-57. DOI: 10.1017/CBO9780511544248.005  0.581
2005 Lichtman AH, Martin BR. Cannabinoid tolerance and dependence. Handbook of Experimental Pharmacology. 691-717. PMID 16596793 DOI: 10.1007/3-540-26573-2_24  0.621
2005 Carroll FI, Brieaddy LE, Navarro HA, Damaj MI, Martin BR. Synthesis and pharmacological characterization of exo-2-(2'-chloro-5-pyridinyl)-7-(endo and exo)-aminobicyclo[2.2.1]heptanes as novel epibatidine analogues. Journal of Medicinal Chemistry. 48: 7491-5. PMID 16279810 DOI: 10.1021/Jm058243V  0.365
2005 Damaj MI, Wiley JL, Martin BR, Papke RL. In vivo characterization of a novel inhibitor of CNS nicotinic receptors. European Journal of Pharmacology. 521: 43-8. PMID 16181622 DOI: 10.1016/J.Ejphar.2005.06.056  0.543
2005 Huffman JW, Szklennik PV, Almond A, Bushell K, Selley DE, He H, Cassidy MP, Wiley JL, Martin BR. 1-Pentyl-3-phenylacetylindoles, a new class of cannabimimetic indoles. Bioorganic & Medicinal Chemistry Letters. 15: 4110-3. PMID 16005223 DOI: 10.1016/J.Bmcl.2005.06.008  0.604
2005 Varvel SA, Bridgen DT, Tao Q, Thomas BF, Martin BR, Lichtman AH. Delta9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice. The Journal of Pharmacology and Experimental Therapeutics. 314: 329-37. PMID 15831444 DOI: 10.1124/Jpet.104.080739  0.804
2005 Wiley JL, Burston JJ, Leggett DC, Alekseeva OO, Razdan RK, Mahadevan A, Martin BR. CB1 cannabinoid receptor-mediated modulation of food intake in mice. British Journal of Pharmacology. 145: 293-300. PMID 15778743 DOI: 10.1038/Sj.Bjp.0706157  0.554
2005 Huffman JW, Zengin G, Wu MJ, Lu J, Hynd G, Bushell K, Thompson AL, Bushell S, Tartal C, Hurst DP, Reggio PH, Selley DE, Cassidy MP, Wiley JL, Martin BR. Structure-activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB(1) and CB(2) receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB(2) receptor agonists. Bioorganic & Medicinal Chemistry. 13: 89-112. PMID 15582455 DOI: 10.1016/J.Bmc.2004.09.050  0.612
2005 Alekseeva OO, Mahadevan A, Wiley JL, Martin BR, Razdan RK. Synthesis of novel 5-substituted pyrazole derivatives as cannabinoid antagonists Tetrahedron Letters. 46: 2159-2161. DOI: 10.1016/J.Tetlet.2005.01.165  0.546
2004 Damaj MI, Hunter RG, Martin BR, Kuhar MJ. Intrathecal CART (55-102) enhances the spinal analgesic actions of morphine in mice. Brain Research. 1024: 146-9. PMID 15451376 DOI: 10.1016/J.Brainres.2004.07.058  0.365
2004 Martin BR, Wiley JL. Mechanism of action of cannabinoids: how it may lead to treatment of cachexia, emesis, and pain. The Journal of Supportive Oncology. 2: 305-14; discussion 3. PMID 15357514  0.444
2004 Damaj MI, Carroll FI, Eaton JB, Navarro HA, Blough BE, Mirza S, Lukas RJ, Martin BR. Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors. Molecular Pharmacology. 66: 675-82. PMID 15322260 DOI: 10.1124/Mol.104.001313  0.356
2004 Carroll FI, Ware R, Brieaddy LE, Navarro HA, Damaj MI, Martin BR. Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2'-fluoro-3'-(substituted phenyl)deschloroepibatidine analogues. Novel nicotinic antagonist. Journal of Medicinal Chemistry. 47: 4588-94. PMID 15317468 DOI: 10.1021/Jm040078G  0.424
2004 Wiley JL, LaVecchia KL, Karp NE, Kulasegram S, Mahadevan A, Razdan RK, Martin BR. A comparison of the discriminative stimulus effects of delta(9)-tetrahydrocannabinol and O-1812, a potent and metabolically stable anandamide analog, in rats. Experimental and Clinical Psychopharmacology. 12: 173-9. PMID 15301634 DOI: 10.1037/1064-1297.12.3.173  0.557
2004 Bass CE, Welch SP, Martin BR. Reversal of delta 9-tetrahydrocannabinol-induced tolerance by specific kinase inhibitors. European Journal of Pharmacology. 496: 99-108. PMID 15288581 DOI: 10.1016/J.Ejphar.2004.06.009  0.628
2004 Selley DE, Cassidy MP, Martin BR, Sim-Selley LJ. Long-term administration of Delta9-tetrahydrocannabinol desensitizes CB1-, adenosine A1-, and GABAB-mediated inhibition of adenylyl cyclase in mouse cerebellum. Molecular Pharmacology. 66: 1275-84. PMID 15286206 DOI: 10.1124/Mol.104.000604  0.377
2004 Martin BR, Sim-Selley LJ, Selley DE. Signaling pathways involved in the development of cannabinoid tolerance. Trends in Pharmacological Sciences. 25: 325-30. PMID 15165748 DOI: 10.1016/J.Tips.2004.04.005  0.339
2004 Baskfield CY, Martin BR, Wiley JL. Differential effects of delta9-tetrahydrocannabinol and methanandamide in CB1 knockout and wild-type mice. The Journal of Pharmacology and Experimental Therapeutics. 309: 86-91. PMID 14718593 DOI: 10.1124/Jpet.103.055376  0.797
2003 Simsek R, Chang-Fong J, Lee M, Dukat M, Imad Damaj M, Martin BR, Glennon RA. Quaternary ammonium 3-(aminoethoxy)pyridines as antinociceptive agents. Bioorganic & Medicinal Chemistry Letters. 13: 2917-20. PMID 14611857 DOI: 10.1016/S0960-894X(03)00585-7  0.413
2003 Wallace MJ, Blair RE, Falenski KW, Martin BR, DeLorenzo RJ. The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy. The Journal of Pharmacology and Experimental Therapeutics. 307: 129-37. PMID 12954810 DOI: 10.1124/Jpet.103.051920  0.308
2003 Damaj MI, Martin BR, Kuhar MJ. Antinociceptive effects of supraspinal rat cart (55-102) peptide in mice. Brain Research. 983: 233-6. PMID 12914986 DOI: 10.1016/S0006-8993(03)03094-4  0.34
2003 Wiley JL, Martin BR. Cannabinoid pharmacological properties common to other centrally acting drugs. European Journal of Pharmacology. 471: 185-93. PMID 12826237 DOI: 10.1016/S0014-2999(03)01856-9  0.618
2003 Huffman JW, Miller JR, Liddle J, Yu S, Thomas BF, Wiley JL, Martin BR. Structure-activity relationships for 1',1'-dimethylalkyl-Delta8-tetrahydrocannabinols. Bioorganic & Medicinal Chemistry. 11: 1397-410. PMID 12628666 DOI: 10.1016/S0968-0896(02)00649-1  0.599
2003 Offertáler L, Mo FM, Bátkai S, Liu J, Begg M, Razdan RK, Martin BR, Bukoski RD, Kunos G. Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor. Molecular Pharmacology. 63: 699-705. PMID 12606780 DOI: 10.1124/Mol.63.3.699  0.387
2003 Huffman JW, Mabon R, Wu MJ, Lu J, Hart R, Hurst DP, Reggio PH, Wiley JL, Martin BR. 3-Indolyl-1-naphthylmethanes: new cannabimimetic indoles provide evidence for aromatic stacking interactions with the CB(1) cannabinoid receptor. Bioorganic & Medicinal Chemistry. 11: 539-49. PMID 12538019 DOI: 10.1016/S0968-0896(02)00451-0  0.594
2003 Breivogel CS, Scates SM, Beletskaya IO, Lowery OB, Aceto MD, Martin BR. The effects of delta9-tetrahydrocannabinol physical dependence on brain cannabinoid receptors. European Journal of Pharmacology. 459: 139-50. PMID 12524139 DOI: 10.1016/S0014-2999(02)02854-6  0.439
2003 Darmani NA, Sim-Selley LJ, Martin BR, Janoyan JJ, Crim JL, Parekh B, Breivogel CS. Antiemetic and motor-depressive actions of CP55,940: cannabinoid CB1 receptor characterization, distribution, and G-protein activation. European Journal of Pharmacology. 459: 83-95. PMID 12505537 DOI: 10.1016/S0014-2999(02)02815-7  0.426
2002 Wiley JL, Martin BR. Cannabinoid pharmacology: implications for additional cannabinoid receptor subtypes. Chemistry and Physics of Lipids. 121: 57-63. PMID 12505690 DOI: 10.1016/S0009-3084(02)00146-9  0.644
2002 Huffman JW, Bushell SM, Miller JR, Wiley JL, Martin BR. 1-Methoxy-, 1-deoxy-11-hydroxy- and 11-hydroxy-1-methoxy-Delta(8)-tetrahydrocannabinols: new selective ligands for the CB2 receptor. Bioorganic & Medicinal Chemistry. 10: 4119-29. PMID 12413866 DOI: 10.1016/S0968-0896(02)00331-0  0.605
2002 Lichtman AH, Martin BR. Marijuana withdrawal syndrome in the animal model. Journal of Clinical Pharmacology. 42: 20S-27S. PMID 12412832 DOI: 10.1002/J.1552-4604.2002.Tb05999.X  0.672
2002 Bass CE, Griffin G, Grier M, Mahadevan A, Razdan RK, Martin BR. SR-141716A-induced stimulation of locomotor activity. A structure-activity relationship study. Pharmacology, Biochemistry, and Behavior. 74: 31-40. PMID 12376150 DOI: 10.1016/S0091-3057(02)00945-0  0.676
2002 Carroll FI, Lee JR, Navarro HA, Ma W, Brieaddy LE, Abraham P, Damaj MI, Martin BR. Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2',3'-disubstituted 5'-pyridinyl)-7-azabicyclo[2.2.1]heptanes: epibatidine analogues. Journal of Medicinal Chemistry. 45: 4755-61. PMID 12361403 DOI: 10.1021/Jm0202268  0.393
2002 Dukat M, El-Zahabi M, Ferretti G, Damaj MI, Martin BR, Young R, Glennon RA. (-)6-n-Propylnicotine antagonizes the antinociceptive effects of (-)nicotine. Bioorganic & Medicinal Chemistry Letters. 12: 3005-7. PMID 12270194 DOI: 10.1016/S0960-894X(02)00614-5  0.39
2002 Sim-Selley LJ, Martin BR. Effect of chronic administration of R-(+)-[2,3-Dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate (WIN55,212-2) or delta(9)-tetrahydrocannabinol on cannabinoid receptor adaptation in mice. The Journal of Pharmacology and Experimental Therapeutics. 303: 36-44. PMID 12235230 DOI: 10.1124/Jpet.102.035618  0.484
2002 Wiley JL, Jefferson RG, Griffin G, Liddle J, Yu S, Huffman JW, Martin BR. Paradoxical pharmacological effects of deoxy-tetrahydrocannabinol analogs lacking high CB1 receptor affinity. Pharmacology. 66: 89-99. PMID 12207116 DOI: 10.1159/000065631  0.645
2002 McKallip RJ, Lombard C, Martin BR, Nagarkatti M, Nagarkatti PS. Delta(9)-tetrahydrocannabinol-induced apoptosis in the thymus and spleen as a mechanism of immunosuppression in vitro and in vivo. The Journal of Pharmacology and Experimental Therapeutics. 302: 451-65. PMID 12130702 DOI: 10.1124/Jpet.102.033506  0.33
2002 Wilson DM, Peart J, Martin BR, Bridgen DT, Byron PR, Lichtman AH. Physiochemical and pharmacological characterization of a Delta(9)-THC aerosol generated by a metered dose inhaler. Drug and Alcohol Dependence. 67: 259-67. PMID 12127197 DOI: 10.1016/S0376-8716(02)00078-9  0.741
2002 McKallip RJ, Lombard C, Fisher M, Martin BR, Ryu S, Grant S, Nagarkatti PS, Nagarkatti M. Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. Blood. 100: 627-34. PMID 12091357 DOI: 10.1182/Blood-2002-01-0098  0.327
2002 Lichtman AH, Varvel SA, Martin BR. Endocannabinoids in cognition and dependence. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 66: 269-85. PMID 12052042 DOI: 10.1054/Plef.2001.0351  0.77
2002 Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, Pertwee RG. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacological Reviews. 54: 161-202. PMID 12037135 DOI: 10.1124/Pr.54.2.161  0.564
2002 Wiley JL, Lavecchia KL, Martin BR, Damaj MI. Nicotine-like discriminative stimulus effects of bupropion in rats. Experimental and Clinical Psychopharmacology. 10: 129-35. PMID 12022798 DOI: 10.1037//1064-1297.10.2.129  0.501
2002 Wiley JL, Beletskaya ID, Ng EW, Dai Z, Crocker PJ, Mahadevan A, Razdan RK, Martin BR. Resorcinol derivatives: a novel template for the development of cannabinoid CB(1)/CB(2) and CB(2)-selective agonists. The Journal of Pharmacology and Experimental Therapeutics. 301: 679-89. PMID 11961073 DOI: 10.1124/Jpet.301.2.679  0.621
2002 Di Marzo V, Griffin G, De Petrocellis L, Brandi I, Bisogno T, Williams W, Grier MC, Kulasegram S, Mahadevan A, Razdan RK, Martin BR. A structure/activity relationship study on arvanil, an endocannabinoid and vanilloid hybrid. The Journal of Pharmacology and Experimental Therapeutics. 300: 984-91. PMID 11861807 DOI: 10.1124/Jpet.300.3.984  0.448
2002 Martin BR, Jefferson RG, Winckler R, Wiley JL, Thomas BF, Crocker PJ, Williams W, Razdan RK. Assessment of structural commonality between tetrahydrocannabinol and anandamide. European Journal of Pharmacology. 435: 35-42. PMID 11790376 DOI: 10.1016/S0014-2999(01)01527-8  0.579
2001 Wallace MJ, Wiley JL, Martin BR, DeLorenzo RJ. Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects. European Journal of Pharmacology. 428: 51-7. PMID 11779037 DOI: 10.1016/S0014-2999(01)01243-2  0.575
2001 Carroll FI, Lee JR, Navarro HA, Brieaddy LE, Abraham P, Damaj MI, Martin BR. Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2'-substituted-3'-phenyl-5'-pyridinyl)-7-azabicyclo[2.2.1]heptanes. Novel nicotinic antagonist. Journal of Medicinal Chemistry. 44: 4039-41. PMID 11708907 DOI: 10.1021/Jm015561V  0.427
2001 Huffman JW, Lu J, Hynd G, Wiley JL, Martin BR. A pyridone analogue of traditional cannabinoids. A new class of selective ligands for the CB(2) receptor. Bioorganic & Medicinal Chemistry. 9: 2863-70. PMID 11597467 DOI: 10.1016/S0968-0896(01)00155-9  0.563
2001 Varvel SA, Hamm RJ, Martin BR, Lichtman AH. Differential effects of delta 9-THC on spatial reference and working memory in mice. Psychopharmacology. 157: 142-50. PMID 11594438 DOI: 10.1007/s002130100780  0.752
2001 Lichtman AH, Sheikh SM, Loh HH, Martin BR. Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice. The Journal of Pharmacology and Experimental Therapeutics. 298: 1007-14. PMID 11504797  0.658
2001 Cravatt BF, Demarest K, Patricelli MP, Bracey MH, Giang DK, Martin BR, Lichtman AH. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proceedings of the National Academy of Sciences of the United States of America. 98: 9371-6. PMID 11470906 DOI: 10.1073/Pnas.161191698  0.68
2001 Lichtman AH, Fisher J, Martin BR. Precipitated cannabinoid withdrawal is reversed by Delta(9)-tetrahydrocannabinol or clonidine. Pharmacology, Biochemistry, and Behavior. 69: 181-8. PMID 11420084 DOI: 10.1016/S0091-3057(01)00514-7  0.675
2001 Breivogel CS, Griffin G, Di Marzo V, Martin BR. Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Molecular Pharmacology. 60: 155-63. PMID 11408610 DOI: 10.1124/Mol.60.1.155  0.387
2001 Lichtman AH, Poklis JL, Poklis A, Wilson DM, Martin BR. The pharmacological activity of inhalation exposure to marijuana smoke in mice. Drug and Alcohol Dependence. 63: 107-16. PMID 11376914 DOI: 10.1016/S0376-8716(00)00205-2  0.74
2001 Wiley JL, Jefferson RG, Grier MC, Mahadevan A, Razdan RK, Martin BR. Novel pyrazole cannabinoids: insights into CB(1) receptor recognition and activation. The Journal of Pharmacology and Experimental Therapeutics. 296: 1013-22. PMID 11181936  0.611
2001 Di Marzo V, Bisogno T, De Petrocellis L, Brandi I, Jefferson RG, Winckler RL, Davis JB, Dasse O, Mahadevan A, Razdan RK, Martin BR. Highly selective CB(1) cannabinoid receptor ligands and novel CB(1)/VR(1) vanilloid receptor "hybrid" ligands. Biochemical and Biophysical Research Communications. 281: 444-51. PMID 11181068 DOI: 10.1006/Bbrc.2001.4354  0.388
2001 Griffin G, Williams S, Aung MM, Razdan RK, Martin BR, Abood ME. Separation of cannabinoid receptor affinity and efficacy in delta-8-tetrahydrocannabinol side-chain analogues. British Journal of Pharmacology. 132: 525-35. PMID 11159703 DOI: 10.1038/Sj.Bjp.0703827  0.4
2000 Ferretti G, Dukat M, Giannella M, Piergentili A, Pigini M, Quaglia W, Damaj MI, Martin BR, Glennon RA. Chain-lengthened and imidazoline analogues of nicotine. Bioorganic & Medicinal Chemistry Letters. 10: 2665-8. PMID 11128647 DOI: 10.1016/S0960-894X(00)00541-2  0.346
2000 Di Marzo V, Breivogel CS, Tao Q, Bridgen DT, Razdan RK, Zimmer AM, Zimmer A, Martin BR. Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain. Journal of Neurochemistry. 75: 2434-44. PMID 11080195 DOI: 10.1046/J.1471-4159.2000.0752434.X  0.446
2000 Damaj MI, Meyer EM, Martin BR. The antinociceptive effects of alpha7 nicotinic agonists in an acute pain model. Neuropharmacology. 39: 2785-91. PMID 11044748 DOI: 10.1016/S0028-3908(00)00139-8  0.374
2000 Di Marzo V, Breivogel C, Bisogno T, Melck D, Patrick G, Tao Q, Szallasi A, Razdan RK, Martin BR. Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide. European Journal of Pharmacology. 406: 363-74. PMID 11040343 DOI: 10.1016/S0014-2999(00)00687-7  0.466
2000 Mahadevan A, Siegel C, Martin BR, Abood ME, Beletskaya I, Razdan RK. Novel cannabinol probes for CB1 and CB2 cannabinoid receptors. Journal of Medicinal Chemistry. 43: 3778-85. PMID 11020293 DOI: 10.1021/Jm0001572  0.402
2000 Wiley JL, Dewey MA, Jefferson RG, Winckler RL, Bridgen DT, Willoughby KA, Martin BR. Influence of phenylmethylsulfonyl fluoride on anandamide brain levels and pharmacological effects. Life Sciences. 67: 1573-83. PMID 10983852 DOI: 10.1016/S0024-3205(00)00749-9  0.528
2000 Aung MM, Griffin G, Huffman JW, Wu M, Keel C, Yang B, Showalter VM, Abood ME, Martin BR. Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB(1) and CB(2) receptor binding. Drug and Alcohol Dependence. 60: 133-40. PMID 10940540 DOI: 10.1016/S0376-8716(99)00152-0  0.354
2000 Bass CE, Martin BR. Time course for the induction and maintenance of tolerance to Delta(9)-tetrahydrocannabinol in mice. Drug and Alcohol Dependence. 60: 113-9. PMID 10940538 DOI: 10.1016/S0376-8716(99)00150-7  0.68
2000 Lichtman AH, Peart J, Poklis JL, Bridgen DT, Razdan RK, Wilson DM, Poklis A, Meng Y, Byron PR, Martin BR. Pharmacological evaluation of aerosolized cannabinoids in mice. European Journal of Pharmacology. 399: 141-9. PMID 10884513 DOI: 10.1016/S0014-2999(00)00321-6  0.815
2000 Wiley JL, Patrick GS, Crocker PC, Saha B, Razdan RK, Martin BR. Antinociceptive effects of tetrahydrocannabinol side chain analogs: dependence upon route of administration. European Journal of Pharmacology. 397: 319-26. PMID 10844130 DOI: 10.1016/S0014-2999(00)00259-4  0.579
2000 Huffman JW, Lu J, Dai D, Kitaygorodskiy A, Wiley JL, Martin BR. Synthesis and pharmacology of a hybrid cannabinoid. Bioorganic & Medicinal Chemistry. 8: 439-47. PMID 10722167 DOI: 10.1016/S0968-0896(99)00305-3  0.568
2000 Beardsley PM, Martin BR. Effects of the cannabinoid CB(1) receptor antagonist, SR141716A, after Delta(9)-tetrahydrocannabinol withdrawal. European Journal of Pharmacology. 387: 47-53. PMID 10633159 DOI: 10.1016/S0014-2999(99)00792-X  0.405
1999 Huffman JW, Liddle J, Yu S, Aung MM, Abood ME, Wiley JL, Martin BR. 3-(1',1'-Dimethylbutyl)-1-deoxy-delta8-THC and related compounds: synthesis of selective ligands for the CB2 receptor. Bioorganic & Medicinal Chemistry. 7: 2905-14. PMID 10658595 DOI: 10.1016/S0968-0896(99)00219-9  0.606
1999 Járai Z, Wagner JA, Varga K, Lake KD, Compton DR, Martin BR, Zimmer AM, Bonner TI, Buckley NE, Mezey E, Razdan RK, Zimmer A, Kunos G. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proceedings of the National Academy of Sciences of the United States of America. 96: 14136-41. PMID 10570211 DOI: 10.1073/pnas.96.24.14136  0.31
1999 Wiley JL, Martin BR. Effects of SR141716A on diazepam substitution for delta9-tetrahydrocannabinol in rat drug discrimination. Pharmacology, Biochemistry, and Behavior. 64: 519-22. PMID 10548265 DOI: 10.1016/S0091-3057(99)00130-6  0.604
1999 Griffin G, Wray EJ, Martin BR, Abood ME. Cannabinoid agonists and antagonists discriminated by receptor binding in rat cerebellum. British Journal of Pharmacology. 128: 684-8. PMID 10516649 DOI: 10.1038/Sj.Bjp.0702806  0.388
1999 Flammia D, Dukat M, Damaj MI, Martin B, Glennon RA. Lobeline: Structure-affinity investigation of nicotinic acetylcholinergic receptor binding Journal of Medicinal Chemistry. 42: 3726-3731. PMID 10479304 DOI: 10.1021/Jm990286M  0.364
1999 Martin BR, Jefferson R, Winckler R, Wiley JL, Huffman JW, Crocker PJ, Saha B, Razdan RK. Manipulation of the tetrahydrocannabinol side chain delineates agonists, partial agonists, and antagonists. The Journal of Pharmacology and Experimental Therapeutics. 290: 1065-79. PMID 10454479  0.558
1999 Griffin G, Wray EJ, Tao Q, McAllister SD, Rorrer WK, Aung MM, Martin BR, Abood ME. Evaluation of the cannabinoid CB2 receptor-selective antagonist, SR144528: further evidence for cannabinoid CB2 receptor absence in the rat central nervous system. European Journal of Pharmacology. 377: 117-25. PMID 10448934 DOI: 10.1016/S0014-2999(99)00402-1  0.376
1999 Ng EW, Aung MM, Abood ME, Martin BR, Razdan RK. Unique analogues of anandamide: arachidonyl ethers and carbamates and norarachidonyl carbamates and ureas. Journal of Medicinal Chemistry. 42: 1975-81. PMID 10354405 DOI: 10.1021/Jm980711W  0.331
1999 Griffin G, Wray EJ, Rorrer WK, Crocker PJ, Ryan WJ, Saha B, Razdan RK, Martin BR, Abood ME. An investigation into the structural determinants of cannabinoid receptor ligand efficacy. British Journal of Pharmacology. 126: 1575-84. PMID 10323589 DOI: 10.1038/Sj.Bjp.0702469  0.349
1999 Meng Y, Dukat M, Bridgen DT, Martin BR, Lichtman AH. Pharmacological effects of methamphetamine and other stimulants via inhalation exposure. Drug and Alcohol Dependence. 53: 111-20. PMID 10080037 DOI: 10.1016/S0376-8716(98)00120-3  0.786
1999 Crocker PJ, Saha B, Ryan WJ, Wiley JL, Martin BR, Ross RA, Pertwee RG, Razdan RK. Development of agonists, partial agonists and antagonists in the Δ8-Tetrahydrocannabinol series Tetrahedron. 55: 13907-13926. DOI: 10.1016/S0040-4020(99)00849-2  0.373
1999 Levin ED, Imad Damaj M, Glassco W, May EL, Martin BR. Bridged nicotine, isonicotine, and norisonicotine effects on working memory performance of rats in the radial-arm maze Drug Development Research. 46: 107-111. DOI: 10.1002/(Sici)1098-2299(199902)46:2<107::Aid-Ddr3>3.0.Co;2-C  0.345
1998 Martin BR, Lichtman AH. Cannabinoid transmission and pain perception. Neurobiology of Disease. 5: 447-61. PMID 9974177 DOI: 10.1006/Nbdi.1998.0218  0.589
1998 Huffman JW, Liddle J, Duncan SG, Yu S, Martin BR, Wiley JL. Synthesis and pharmacology of the isomeric methylheptyl-delta8-tetrahydrocannabinols. Bioorganic & Medicinal Chemistry. 6: 2383-96. PMID 9925296 DOI: 10.1016/S0968-0896(98)80014-X  0.546
1998 Liddle J, Huffman JW, Wiley JL, Martin BR. Enantioselective synthesis and pharmacology of 11-hydroxy-(1'S,2'R)-dimethylheptyl-delta 8-THC. Bioorganic & Medicinal Chemistry Letters. 8: 2223-6. PMID 9873517 DOI: 10.1016/S0960-894X(98)00385-0  0.518
1998 Lichtman AH, Wiley JL, LaVecchia KL, Neviaser ST, Arthur DB, Wilson DM, Martin BR. Effects of SR 141716A after acute or chronic cannabinoid administration in dogs. European Journal of Pharmacology. 357: 139-48. PMID 9797029 DOI: 10.1016/S0014-2999(98)00558-5  0.725
1998 Singer M, Ryan WJ, Saha B, Martin BR, Razdan RK. Potent cyano and carboxamido side-chain analogues of 1', 1'-dimethyl-delta8-tetrahydrocannabinol. Journal of Medicinal Chemistry. 41: 4400-7. PMID 9784115 DOI: 10.1021/Jm9803875  0.309
1998 Wiley JL, Ryan WJ, Razdan RK, Martin BR. Evaluation of cannabimimetic effects of structural analogs of anandamide in rats. European Journal of Pharmacology. 355: 113-8. PMID 9760024 DOI: 10.1016/S0014-2999(98)00502-0  0.612
1998 Cook SA, Lowe JA, Martin BR. CB1 receptor antagonist precipitates withdrawal in mice exposed to Delta9-tetrahydrocannabinol. The Journal of Pharmacology and Experimental Therapeutics. 285: 1150-6. PMID 9618417  0.333
1998 Wiley JL, Compton DR, Dai D, Lainton JA, Phillips M, Huffman JW, Martin BR. Structure-activity relationships of indole- and pyrrole-derived cannabinoids. The Journal of Pharmacology and Experimental Therapeutics. 285: 995-1004. PMID 9618400  0.548
1998 Adams IB, Compton DR, Martin BR. Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain. The Journal of Pharmacology and Experimental Therapeutics. 284: 1209-17. PMID 9495885  0.32
1997 Wiley JL, Golden KM, Ryan WJ, Balster RL, Razdan RK, Martin BR. Evaluation of cannabimimetic discriminative stimulus effects of anandamide and methylated fluoroanandamide in rhesus monkeys. Pharmacology, Biochemistry, and Behavior. 58: 1139-43. PMID 9408225 DOI: 10.1016/S0091-3057(97)00327-4  0.613
1997 Compton DR, Martin BR. The effect of the enzyme inhibitor phenylmethylsulfonyl fluoride on the pharmacological effect of anandamide in the mouse model of cannabimimetic activity. The Journal of Pharmacology and Experimental Therapeutics. 283: 1138-43. PMID 9399986  0.329
1997 Wagner JA, Varga K, Ellis EF, Rzigalinski BA, Martin BR, Kunos G. Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock. Nature. 390: 518-21. PMID 9394002 DOI: 10.1038/37371  0.376
1997 Reggio PH, Wang T, Brown AE, Fleming DN, Seltzman HH, Griffin G, Pertwee RG, Compton DR, Abood ME, Martin BR. Importance of the C-1 substituent in classical cannabinoids to CB2 receptor selectivity: synthesis and characterization of a series of O,2-propano-delta 8-tetrahydrocannabinol analogs. Journal of Medicinal Chemistry. 40: 3312-8. PMID 9379452 DOI: 10.1021/Jm970136G  0.374
1997 Seltzman HH, Fleming DN, Thomas BF, Gilliam AF, McCallion DS, Pertwee RG, Compton DR, Martin BR. Synthesis and pharmacological comparison of dimethylheptyl and pentyl analogs of anandamide. Journal of Medicinal Chemistry. 40: 3626-34. PMID 9357529 DOI: 10.1021/Jm9702950  0.392
1997 Ryan WJ, Banner WK, Wiley JL, Martin BR, Razdan RK. Potent anandamide analogs: the effect of changing the length and branching of the end pentyl chain. Journal of Medicinal Chemistry. 40: 3617-25. PMID 9357528 DOI: 10.1021/jm970212f  0.497
1997 Dutta AK, Ryan W, Thomas BF, Singer M, Compton DR, Martin BR, Razdan RK. Synthesis, pharmacology, and molecular modeling of novel 4-alkyloxy indole derivatives related to cannabimimetic aminoalkyl indoles (AAIs). Bioorganic & Medicinal Chemistry. 5: 1591-600. PMID 9313864 DOI: 10.1016/S0968-0896(97)00111-9  0.391
1997 Meng Y, Lichtman AH, Bridgen DT, Martin BR. Inhalation studies with drugs of abuse. Nida Research Monograph. 173: 201-24. PMID 9260190  0.555
1997 Damaj MI, Patrick GS, Creasy KR, Martin BR. Pharmacology of lobeline, a nicotinic receptor ligand. The Journal of Pharmacology and Experimental Therapeutics. 282: 410-9. PMID 9223582  0.332
1997 Lake KD, Compton DR, Varga K, Martin BR, Kunos G. Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors. The Journal of Pharmacology and Experimental Therapeutics. 281: 1030-7. PMID 9190833  0.344
1997 Lichtman AH, Martin BR. The selective cannabinoid antagonist SR 141716A blocks cannabinoid-induced antinociception in rats. Pharmacology, Biochemistry, and Behavior. 57: 7-12. PMID 9164547 DOI: 10.1016/S0091-3057(96)00121-9  0.69
1997 Lake KD, Martin BR, Kunos G, Varga K. Cardiovascular effects of anandamide in anesthetized and conscious normotensive and hypertensive rats. Hypertension. 29: 1204-10. PMID 9149688 DOI: 10.1161/01.Hyp.29.5.1204  0.323
1997 Huffman JW, Duncan SG, Wiley JL, Martin BR. Synthesis and pharmacology of the 1',2'-dimethylheptyl-Δ8-THC isomers: Exceptionally potent cannabinoids Bioorganic and Medicinal Chemistry Letters. 7: 2799-2804. DOI: 10.1016/S0960-894X(97)10086-5  0.528
1997 Ryan WJ, Banner WK, Crocker PJ, Martin BR, Razdan RK. Synthesis of (+)- and (-)-2-methylarachidonyl-2'-fluoroethylamide (O-689) Bioorganic & Medicinal Chemistry Letters. 7: 2669-2672. DOI: 10.1016/S0960-894X(97)10047-6  0.347
1997 Singer M, Dutta AK, Compton DR, Martin BR, Razdan RK. Synthesis and pharmacology of (R)- and (S)-4'-hydroxy-Δ9-tetrahydrocannabinols European Journal of Medicinal Chemistry. 32: 165-170. DOI: 10.1016/S0223-5234(97)87544-7  0.309
1997 Huffman JW, Lainton JAH, Banner WK, Duncan SG, Jordan RD, Yu S, Dai D, Martin BR, Wiley JL, Compton DR. Side chain methyl analogues of Δ8-THC Tetrahedron. 53: 1557-1576. DOI: 10.1016/S0040-4020(96)01134-9  0.524
1996 Wiley JL, Compton DR, Gordon PM, Siegel C, Singer M, Dutta A, Lichtman AH, Balster RL, Razdan RK, Martin BR. Evaluation of agonist-antagonist properties of nitrogen mustard and cyano derivatives of delta 8-tetrahydrocannabinol. Neuropharmacology. 35: 1793-804. PMID 9076759 DOI: 10.1016/S0028-3908(96)00120-7  0.775
1996 Pertwee RG, Fernando SR, Griffin G, Ryan W, Razdan RK, Compton DR, Martin BR. Agonist-antagonist characterization of 6'-cyanohex-2'-yne-delta 8-tetrahydrocannabinol in two isolated tissue preparations. European Journal of Pharmacology. 315: 195-201. PMID 8960884 DOI: 10.1016/S0014-2999(96)00631-0  0.372
1996 Meng Y, Lichtman AH, Bridgen DT, Martin BR. Pharmacological potency and biodisposition of phencyclidine via inhalation exposure in mice. Drug and Alcohol Dependence. 43: 13-22. PMID 8957139 DOI: 10.1016/S0376-8716(96)01284-7  0.797
1996 Abood ME, Martin BR. Molecular neurobiology of the cannabinoid receptor International Review of Neurobiology. 197-221. PMID 8894848 DOI: 10.1016/S0074-7742(08)60667-4  0.382
1996 Lichtman AH, Meng Y, Martin BR. Inhalation exposure to volatilized opioids produces antinociception in mice. The Journal of Pharmacology and Experimental Therapeutics. 279: 69-76. PMID 8858977  0.649
1996 Lichtman AH, Martin BR. Delta 9-tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism. Psychopharmacology. 126: 125-31. PMID 8856831 DOI: 10.1007/Bf02246347  0.647
1996 Huffman JW, Yu S, Showalter V, Abood ME, Wiley JL, Compton DR, Martin BR, Bramblett RD, Reggio PH. Synthesis and pharmacology of a very potent cannabinoid lacking a phenolic hydroxyl with high affinity for the CB2 receptor. Journal of Medicinal Chemistry. 39: 3875-7. PMID 8831752 DOI: 10.1021/Jm960394Y  0.603
1996 Damaj MI, Martin BR. Tolerance to the antinociceptive effect of epibatidine after acute and chronic administration in mice. European Journal of Pharmacology. 300: 51-7. PMID 8741164 DOI: 10.1016/0014-2999(95)00834-9  0.398
1996 Fan F, Tao Q, Abood M, Martin BR. Cannabinoid receptor down-regulation without alteration of the inhibitory effect of CP 55,940 on adenylyl cyclase in the cerebellum of CP 55,940-tolerant mice Brain Research. 706: 13-20. PMID 8720487 DOI: 10.1016/0006-8993(95)01113-7  0.463
1996 Lichtman AH, Cook SA, Martin BR. Investigation of brain sites mediating cannabinoid-induced antinociception in rats: evidence supporting periaqueductal gray involvement. The Journal of Pharmacology and Experimental Therapeutics. 276: 585-93. PMID 8632325  0.649
1996 Shivachar AC, Martin BR, Ellis EF. Anandamide- and delta9-tetrahydrocannabinol-evoked arachidonic acid mobilization and blockade by SR141716A [N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4 -methyl-1H-pyrazole-3-carboximide hydrochloride]. Biochemical Pharmacology. 51: 669-76. PMID 8615904 DOI: 10.1016/S0006-2952(95)02248-1  0.354
1996 Dukat M, Fiedler W, Dumas D, Damaj I, Martin BR, Rosecrans JA, James JR, Glennon RA. Pyrrolidine-modified and 6-substituted analogs of nicotine: A structure-affinity investigation European Journal of Medicinal Chemistry. 31: 875-888. DOI: 10.1016/S0223-5234(97)89850-9  0.364
1996 Imad Damaj M, Glassco W, Dukat M, May EL, Glennon RA, Martin BR. Pharmacology of novel nicotinic analogs Drug Development Research. 38: 177-187. DOI: 10.1002/(Sici)1098-2299(199607/08)38:3/4<177::Aid-Ddr6>3.0.Co;2-J  0.375
1995 Wiley JL, Huffman JW, Balster RL, Martin BR. Pharmacological specificity of the discriminative stimulus effects of delta 9-tetrahydrocannabinol in rhesus monkeys. Drug and Alcohol Dependence. 40: 81-6. PMID 8746928 DOI: 10.1016/0376-8716(95)01193-5  0.589
1995 Damaj MI, Creasy KR, Welch SP, Rosecrans JA, Aceto MD, Martin BR. Comparative pharmacology of nicotine and ABT-418, a new nicotinic agonist. Psychopharmacology. 120: 483-90. PMID 8539331 DOI: 10.1007/Bf02245822  0.36
1995 Martin BR, Compton DR, Prescott WR, Barrett RL, Razdan RK. Pharmacological evaluation of dimethylheptyl analogs of delta 9-THC: reassessment of the putative three-point cannabinoid-receptor interaction. Drug and Alcohol Dependence. 37: 231-40. PMID 7796717 DOI: 10.1016/0376-8716(94)01081-U  0.405
1995 Adams IB, Ryan W, Singer M, Thomas BF, Compton DR, Razdan RK, Martin BR. Evaluation of cannabinoid receptor binding and in vivo activities for anandamide analogs. The Journal of Pharmacology and Experimental Therapeutics. 273: 1172-81. PMID 7791088  0.302
1995 Wiley J, Balster R, Martin B. Discriminative stimulus effects of anandamide in rats. European Journal of Pharmacology. 276: 49-54. PMID 7781695 DOI: 10.1016/0014-2999(95)00010-I  0.441
1995 Wenger T, Tóth BE, Martin BR. Effects of anandamide (endogen cannabinoid) on anterior pituitary hormone secretion in adult ovariectomized rats. Life Sciences. 56: 2057-63. PMID 7776832 DOI: 10.1016/0024-3205(95)00189-D  0.301
1995 Cook SA, Welch SP, Lichtman AH, Martin BR. Evaluation of cAMP involvement in cannabinoid-induced antinociception. Life Sciences. 56: 2049-56. PMID 7776831 DOI: 10.1016/0024-3205(95)00188-C  0.681
1995 Adams IB, Ryan W, Singer M, Razdan RK, Compton DR, Martin BR. Pharmacological and behavioral evaluation of alkylated anandamide analogs. Life Sciences. 56: 2041-8. PMID 7776830 DOI: 10.1016/0024-3205(95)00187-B  0.377
1995 Ryan W, Singer M, Razdan RK, Compton DR, Martin BR. A novel class of potent tetrahydrocannabinols (THCS): 2'-yne-delta 8- and delta 9-THCS. Life Sciences. 56: 2013-20. PMID 7776826 DOI: 10.1016/0024-3205(95)00183-7  0.428
1995 Damaj MI, Welch SP, Martin BR. In vivo pharmacological effects of dihydro-β-erythroidine, a nicotinic antagonist, in mice Psychopharmacology. 117: 67-73. PMID 7724704 DOI: 10.1007/Bf02245100  0.37
1995 Lichtman AH, Dimen KR, Martin BR. Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats. Psychopharmacology. 119: 282-90. PMID 7675962 DOI: 10.1007/Bf02246292  0.648
1995 Glennon RA, Young R, Martin BR, Dal Cason TA. Methcathinone ("cat"): An enantiomeric potency comparison Pharmacology, Biochemistry and Behavior. 50: 601-606. PMID 7617707 DOI: 10.1016/0091-3057(94)00348-3  0.324
1995 Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, Gopher A, Almog S, Martin BR, Compton DR. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochemical Pharmacology. 50: 83-90. PMID 7605349 DOI: 10.1016/0006-2952(95)00109-D  0.377
1995 Varga K, Lake K, Martin BR, Kunos G. Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide. European Journal of Pharmacology. 278: 279-83. PMID 7589169 DOI: 10.1016/0014-2999(95)00181-J  0.404
1995 Barrett RL, Wiley JL, Balster RL, Martin BR. Pharmacological specificity of delta 9-tetrahydrocannabinol discrimination in rats. Psychopharmacology. 118: 419-24. PMID 7568628 DOI: 10.1007/Bf02245942  0.605
1995 Wiley JL, Barrett RL, Lowe J, Balster RL, Martin BR. Discriminative stimulus effects of CP 55,940 and structurally dissimilar cannabinoids in rats. Neuropharmacology. 34: 669-76. PMID 7566504 DOI: 10.1016/0028-3908(95)00027-4  0.617
1995 Wiley JL, Lowe JA, Balster RL, Martin BR. Antagonism of the discriminative stimulus effects of delta 9-tetrahydrocannabinol in rats and rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 275: 1-6. PMID 7562536  0.588
1995 Lichtman AH, Sathe P, Dimen KR, Martin BR. Acute tolerance to the cardiovascular effects of volatilized cocaine free base in rats. Drug and Alcohol Dependence. 38: 247-54. PMID 7555625 DOI: 10.1016/0376-8716(95)01111-B  0.594
1994 Damaj MI, Glennon RA, Martin BR. Involvement of the serotonergic system in the hypoactive and antinociceptive effects of nicotine in mice. Brain Research Bulletin. 33: 199-203. PMID 8275340 DOI: 10.1016/0361-9230(94)90252-6  0.377
1994 Martin BR, Welch SP, Abood M. Progress toward Understanding the Cannabinoid Receptor and Its Second Messenger Systems Advances in Pharmacology (San Diego). 25: 341-397. PMID 8204506 DOI: 10.1016/S1054-3589(08)60437-8  0.374
1994 Yan G, Yin D, Khanolkar AD, Compton DR, Martin BR, Makriyannis A. Synthesis and pharmacological properties of 11-hydroxy-3-(1',1'-dimethylheptyl)hexahydrocannabinol: a high-affinity cannabinoid agonist. Journal of Medicinal Chemistry. 37: 2619-22. PMID 8057304 DOI: 10.1021/Jm00042A015  0.335
1994 Damaj MI, Welch SP, Martin BR. Nicotine-induced antinociception in mice: Role of G-proteins and adenylate cyclase Pharmacology, Biochemistry and Behavior. 48: 37-42. PMID 8029303 DOI: 10.1016/0091-3057(94)90494-4  0.387
1994 McLaughlin CR, Martin BR, Compton DR, Abood ME. Cannabinoid receptors in developing rats: detection of mRNA and receptor binding. Drug and Alcohol Dependence. 36: 27-31. PMID 7988356 DOI: 10.1016/0376-8716(94)90006-X  0.371
1994 Mechoulam R, Hanuš L, Martin BR. Search for endogenous ligands of the cannabinoid receptor. Biochemical Pharmacology. 48: 1537-1544. PMID 7980618 DOI: 10.1016/0006-2952(94)90197-X  0.321
1994 May EL, Aceto MD, Bowman ER, Bentley C, Martin BR, Harris LS, Medzihradsky F, Mattson MV, Jacobson AE. Antipodal alpha-N-(methyl through decyl)-N-normetazocines (5,9 alpha-dimethyl-2'-hydroxy-6,7-benzomorphans): in vitro and in vivo properties. Journal of Medicinal Chemistry. 37: 3408-18. PMID 7932569 DOI: 10.1021/Jm00046A026  0.606
1994 Damaj MI, Creasy KR, Grove AD, Rosecrans JA, Martin BR. Pharmacological effects of epibatidine optical enantiomers. Brain Research. 664: 34-40. PMID 7895043 DOI: 10.1016/0006-8993(94)91950-X  0.387
1994 Huffman JW, Dai D, Martin BR, Compton DR. Design, Synthesis and Pharmacology of Cannabimimetic Indoles Bioorganic and Medicinal Chemistry Letters. 4: 563-566. DOI: 10.1016/S0960-894X(01)80155-4  0.355
1994 Lichtman AH, Martin BR. Changes in tail skin temperature are unlikely to be a confounding factor in the tail-flick test Pain. 57: 257-258. DOI: 10.1016/0304-3959(94)90235-6  0.572
1993 Wiley JL, Barrett RL, Balster RL, Martin BR. Tolerance to the discriminative stimulus effects of Delta(9)-tetrahydrocannabinol. Behavioural Pharmacology. 4: 581-585. PMID 11224227  0.534
1993 Wiley JL, Barrett RL, Britt DT, Balster RL, Martin BR. Discriminative stimulus effects of delta 9-tetrahydrocannabinol and delta 9-11-tetrahydrocannabinol in rats and rhesus monkeys. Neuropharmacology. 32: 359-65. PMID 8388551 DOI: 10.1016/0028-3908(93)90157-X  0.594
1993 Lu R, Hubbard JR, Martin BR, Kalimi MY. Roles of sulfhydryl and disulfide groups in the binding of CP-55,940 to rat brain cannabinoid receptor. Molecular and Cellular Biochemistry. 121: 119-26. PMID 8316228 DOI: 10.1007/Bf00925970  0.368
1993 Abood ME, Sauss C, Fan F, Tilton CL, Martin BR. Development of behavioral tolerance to Δ9-THC without alteration of cannabinoid receptor binding or mRNA levels in whole brain Pharmacology, Biochemistry and Behavior. 46: 575-579. PMID 8278434 DOI: 10.1016/0091-3057(93)90546-6  0.409
1993 Glassco W, Suchocki J, George C, Martin BR, May EL. Synthesis, optical resolution, absolute configuration, and preliminary pharmacology of (+)- and (-)-cis-2,3,3a,4,5,9b-hexahydro-1-methyl-1H- pyrrolo-[3,2-h]isoquinoline, a structural analog of nicotine. Journal of Medicinal Chemistry. 36: 3381-5. PMID 8230128 DOI: 10.1021/Jm00074A019  0.358
1993 Lichtman AH, Smith FL, Martin BR. Evidence that the antinociceptive tail-flick response is produced independently from changes in either tail-skin temperature or core temperature. Pain. 55: 283-95. PMID 8121689 DOI: 10.1016/0304-3959(93)90003-8  0.609
1993 Damaj MI, Martin BR. Is the dopaminergic system involved in the central effects of nicotine in mice Psychopharmacology. 111: 106-108. PMID 7870924 DOI: 10.1007/Bf02257415  0.366
1993 Damaj MI, Martin BR. Calcium agonists and antagonists of the dihydropyridine type: effect on nicotine-induced antinociception and hypomotility. Drug and Alcohol Dependence. 32: 73-9. PMID 7683598 DOI: 10.1016/0376-8716(93)90024-K  0.336
1993 Wiley JL, Barrett RL, Balster RL, Martin BR. Tolerance to the discriminative stimulus effects of Δ9-tetrahydrocannabinol Behavioural Pharmacology. 4: 581-585. DOI: 10.1097/00008877-199312000-00004  0.521
1992 Darmani NA, Martin BR, Glennon RA. Repeated administration of low doses of cocaine enhances the sensitivity of 5-HT2 receptor function. Pharmacology, Biochemistry, and Behavior. 41: 519-27. PMID 1584831 DOI: 10.1016/0091-3057(92)90367-O  0.33
1992 Lichtman AH, Smith PB, Martin BR. The antinociceptive effects of intrathecally administered cannabinoids are influenced by lipophilicity. Pain. 51: 19-26. PMID 1454400 DOI: 10.1016/0304-3959(92)90004-U  0.681
1992 Darmani NA, Schnoll SH, Pandey U, Martin BR. Chronic prenatal methadone exposure alters central opioid μ-receptor affinity in both fetal and maternal brain Neurotoxicology and Teratology. 14: 265-271. PMID 1326078 DOI: 10.1016/0892-0362(92)90006-V  0.372
1992 Smith PB, Martin BR. Spinal mechanisms ofΔ9-tetrahydrocannabinol-induced analgesia Brain Research. 578: 8-12. PMID 1324767 DOI: 10.1016/0006-8993(92)90222-U  0.341
1992 Charalambous A, Yan G, Houston DB, Howlett AC, Compton DR, Martin BR, Makriyannis A. 5'-Azido-delta 8-THC: a novel photoaffinity label for the cannabinoid receptor. Journal of Medicinal Chemistry. 35: 3076-9. PMID 1323683 DOI: 10.1021/Jm00094A023  0.594
1992 Carroll FI, Abraham P, Parham K, Bai X, Zhang X, Brine GA, Mascarella SW, Martin BR, May EL, Sauss C. Enantiomeric N-substituted N-normetazocines: a comparative study of affinities at sigma, PCP, and mu opioid receptors. Journal of Medicinal Chemistry. 35: 2812-8. PMID 1322987 DOI: 10.1021/Jm00093A014  0.381
1992 Prescott WR, Gold LH, Martin BR. Evidence for separate neuronal mechanisms for the discriminative stimulus and catalepsy induced by delta 9-THC in the rat. Psychopharmacology. 107: 117-24. PMID 1317040 DOI: 10.1007/Bf02244975  0.373
1991 Darmani NA, Martin BR, Pandey U, Glennon RA. Pharmacological characterization of ear-scratch response in mice as a behavioral model for selective 5-HT2-receptor agonists and evidence for 5-HT1B- and 5-HT2-receptor interactions. Pharmacology, Biochemistry, and Behavior. 37: 95-9. PMID 2263671 DOI: 10.1016/0091-3057(90)90047-L  0.364
1991 Glennon RA, Darmani NA, Martin BR. Multiple populations of serotonin receptors may modulate the behavioral effects of serotonergic agents. Life Sciences. 48: 2493-8. PMID 2046474 DOI: 10.1016/0024-3205(91)90603-9  0.318
1991 Suchocki JA, May EL, Martin TJ, George C, Martin BR. Synthesis of 2-exo- and 2-endo-mecamylamine analogues. Structure-activity relationships for nicotinic antagonism in the central nervous system. Journal of Medicinal Chemistry. 34: 1003-10. PMID 2002445 DOI: 10.1021/Jm00107A019  0.35
1991 Little PJ, Martin BR. The effects of Δ9-tetrahydrocannabinol and other cannabinoids on cAMP accumulation in synaptosomes Life Sciences. 48: 1133-1141. PMID 1848340 DOI: 10.1016/0024-3205(91)90450-P  0.378
1991 Darmani NA, Martin BR, Pandey U, Glennon RA. Inhibition of 5-HT2 receptor-mediated head-twitch response by cocaine via indirect stimulation of adrenergic alpha 2 and serotonergic 5-HT1A receptors. Pharmacology, Biochemistry, and Behavior. 38: 353-7. PMID 1676173 DOI: 10.1016/0091-3057(91)90290-I  0.345
1991 Lichtman AH, Martin BR. Cannabinoid-induced antinociception is mediated by a spinal alpha 2-noradrenergic mechanism. Brain Research. 559: 309-14. PMID 1665384 DOI: 10.1016/0006-8993(91)90017-P  0.652
1991 Compton DR, Prescott WR, Martin BR, Siegel C, Gordon PM, Razdan RK. Synthesis and pharmacological evaluation of ether and related analogues of delta 8-, delta 9-, and delta 9,11-tetrahydrocannabinol. Journal of Medicinal Chemistry. 34: 3310-6. PMID 1659638 DOI: 10.1021/Jm00115A023  0.467
1991 Lichtman AH, Martin BR. Spinal and supraspinal components of cannabinoid-induced antinociception. The Journal of Pharmacology and Experimental Therapeutics. 258: 517-23. PMID 1650831  0.589
1991 Darmani NA, Schnoll SH, Fuchs B, Martin BR. Does chronic prenatal methadone exposure affect β-receptor subtypes in placental, fetal and maternal brain homogenates? Neurotoxicology and Teratology. 13: 43-48. PMID 1646380 DOI: 10.1016/0892-0362(91)90026-S  0.312
1990 Compton DR, Martin BR. Pharmacological evaluation of water soluble cannabinoids and related analogs. Life Sciences. 46: 1575-85. PMID 2352451 DOI: 10.1016/0024-3205(90)90391-4  0.329
1990 Compton DR, Dewey WL, Martin BR. Cannabis dependence and tolerance production. Advances in Alcohol & Substance Abuse. 9: 129-47. PMID 2165734 DOI: 10.1300/J251V09N01_08  0.53
1990 Semus SF, Martin BR. A computergraphic investigation into the pharmacological role of the THC-cannabinoid phenolic moiety. Life Sciences. 46: 1781-1785. PMID 2163002 DOI: 10.1016/0024-3205(90)90142-E  0.339
1990 Onaivi ES, Green MR, Martin BR. Pharmacological characterization of cannabinoids in the elevated plus maze. The Journal of Pharmacology and Experimental Therapeutics. 253: 1002-9. PMID 2162942  0.33
1990 Compton DR, Little PJ, Martin BR, Gilman JW, Saha JK, Jorapur VS, Sard HP, Razdan RK. Synthesis and pharmacological evaluation of amino, azido, and nitrogen mustard analogues of 10-substituted cannabidiol and 11- or 12-substituted delta 8-tetrahydrocannabinol. Journal of Medicinal Chemistry. 33: 1437-43. PMID 2158563 DOI: 10.1021/Jm00167A025  0.416
1990 Todd SL, Balster RL, Martin BR. Affinity of the enantiomers of α- and β-cyclazocine for binding to the phencyclidine and μ opioid receptors Life Sciences. 46: 895-901. PMID 2157122 DOI: 10.1016/0024-3205(90)90120-G  0.347
1990 Darmani NA, Martin BR, Pandey U, Glennon RA. Do functional relationships exist between 5-HT1A and 5-HT2 receptors? Pharmacology, Biochemistry, and Behavior. 36: 901-6. PMID 2145593 DOI: 10.1016/0091-3057(90)90098-3  0.325
1990 Lichtman AH, Martin BR. Spinal action of cannabinoid-induced antinociception. Nida Research Monograph. 105: 422-4. PMID 1876060  0.568
1989 Glennon RA, Ismaiel AE, Martin B, Poff D, Sutton M. A preliminary behavioral investigation of PMMA, the 4-methoxy analog of methamphetamine. Pharmacology, Biochemistry, and Behavior. 31: 9-13. PMID 3252264 DOI: 10.1016/0091-3057(88)90303-6  0.386
1989 Onaivi ES, Todd S, Martin BR. Behavioral effects in the mouse during and following withdrawal from ethanol ingestion and/or nicotine administration Drug and Alcohol Dependence. 24: 205-211. PMID 2605996 DOI: 10.1016/0376-8716(89)90057-4  0.316
1989 Onaivi ES, Martin BR. Neuropharmacological and physiological validation of a computer-controlled two-compartment black and white box for the assessment of anxiety. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 13: 963-976. PMID 2573111 DOI: 10.1016/0278-5846(89)90047-X  0.326
1989 Little PJ, Compton DR, Mechoulam R, Martin BR. Stereochemical effects of 11-OH-delta 8-THC-dimethylheptyl in mice and dogs. Pharmacology, Biochemistry, and Behavior. 32: 661-6. PMID 2544901 DOI: 10.1016/0091-3057(89)90014-2  0.408
1989 Compton DR, Little PJ, Martin BR, Saha JK, Gilman J, Sard H, Razdan RK. Synthesis and pharmacological evaluation of mercapto and thioacetyl analogues of cannabidiol and Δ8-tetrahydrocannabinol European Journal of Medicinal Chemistry. 24: 293-297. DOI: 10.1016/0223-5234(89)90012-3  0.352
1988 Lyddane JE, Thomas BF, Compton DR, Martin BR. Modification of phencyclidine intoxification and biodisposition by charcoal and other treatments. Pharmacology, Biochemistry, and Behavior. 30: 371-7. PMID 3174769 DOI: 10.1016/0091-3057(88)90470-4  0.306
1988 Scimeca JA, Martin BR. The Effect of Acute Dyflos (DFP) Treatment on [3H]Nicotine Binding to Mouse Brain Homogenate Journal of Pharmacy and Pharmacology. 40: 793-797. PMID 2907560 DOI: 10.1111/J.2042-7158.1988.Tb05174.X  0.361
1987 Estrada U, Brase DA, Martin BR, Dewey WL. Cardiovascular effects of delta 9- and delta 9(11)-tetrahydrocannabinol and their interaction with epinephrine. Life Sciences. 41: 79-87. PMID 3037218 DOI: 10.1016/0024-3205(87)90559-5  0.553
1987 Beardsley PM, Scimeca JA, Martin BR. Studies on the agonistic activity of delta 9-11-tetrahydrocannabinol in mice, dogs and rhesus monkeys and its interactions with delta 9-tetrahydrocannabinol. The Journal of Pharmacology and Experimental Therapeutics. 241: 521-6. PMID 3033218  0.316
1986 Kachur JF, May EL, Awaya H, Egle JL, Aceto MD, Martin BR. Pharmacological effects of 1,2,3,5,6,10b-hexahydropyrido[2,3g]indolizine, a bridged-nicotine analog. Life Sciences. 38: 323-30. PMID 3945165 DOI: 10.1016/0024-3205(86)90079-2  0.332
1986 Aceto MD, Bagley RS, Dewey WL, Fu TC, Martin BR. The spinal cord as a major site for the antinociceptive action of nicotine in the rat. Neuropharmacology. 25: 1031-6. PMID 3774124 DOI: 10.1016/0028-3908(86)90198-X  0.516
1985 Kachur JF, Rosemond R, Welch S, Bowman ER, Martin BR, Brase DA, Dewey WL. Comparison of the ability of opioid analgesics to increase endogenous opioid-like activity in the cerebrospinal fluid of rabbits. Life Sciences. 37: 2549-55. PMID 4079662 DOI: 10.1016/0024-3205(85)90613-7  0.546
1985 Reynolds ML, Little PJ, Thomas BF, Bagley RB, Martin BR. Relationship between the biodisposition of [3H]soman and its pharmacological effects in mice. Toxicology and Applied Pharmacology. 80: 409-20. PMID 4035696 DOI: 10.1016/0041-008X(85)90385-0  0.3
1985 Wessinger WD, Martin BR, Balster RL. Discriminative stimulus properties and brain distribution of phencyclidine in rats following administration by injection and smoke inhalation Pharmacology, Biochemistry and Behavior. 23: 607-612. PMID 2999833 DOI: 10.1016/0091-3057(85)90425-3  0.352
1985 Jorapur VS, Khalil ZH, Duffley RP, Razdan RK, Martin BR, Harris LS, Dewey WL. Hashish: synthesis and central nervous system activity of some novel analogues of cannabidiol and oxepin derivatives of delta 9-tetrahydrocannabinol. Journal of Medicinal Chemistry. 28: 783-7. PMID 2989518 DOI: 10.1021/Jm00383A016  0.67
1985 Martin BR. Structural requirements for cannabinoid-induced antinociceptive activity in mice Life Sciences. 36: 1523-1530. PMID 2984503 DOI: 10.1016/0024-3205(85)90376-5  0.357
1984 Freeman AS, Martin BR, Balster RL. Relationship between the development of behavioral tolerance and the biodisposition of phencyclidine in mice. Pharmacology, Biochemistry, and Behavior. 20: 373-7. PMID 6709671 DOI: 10.1016/0091-3057(84)90273-9  0.377
1984 Martin BR, Reynolds ML, Harris LS, Toro-Goyco E. Binding of [3H]phenycyclidine to rat and human blood constituents. Biochemical Pharmacology. 33: 429-34. PMID 6704162 DOI: 10.1016/0006-2952(84)90236-3  0.495
1984 Robertson LR, Duffley RP, Razdan RK, Martin BR, Harris LS, Dewey WL. Synthesis and pharmacological activity of some 9-substituted delta 8-tetrahydrocannabinol analogues. Journal of Medicinal Chemistry. 27: 550-2. PMID 6323713 DOI: 10.1021/Jm00370A023  0.652
1984 Shook JE, Kallman MJ, Martin BR, Dewey WL. Characterization of the interaction of pentazocine and tripelennamine: drug discrimination and mu-receptor binding assay. Pharmacology, Biochemistry, and Behavior. 21: 877-81. PMID 6097919 DOI: 10.1016/S0091-3057(84)80068-4  0.573
1984 Martin BR, Katzen JS, Woods JA, Tripathi HL, Harris LS, May EL. Stereoisomers of [3H]-N-allylnormetazocine bind to different sites in mouse brain. The Journal of Pharmacology and Experimental Therapeutics. 231: 539-44. PMID 6094791  0.454
1984 Martin BR, Kallman MJ, Kaempf GF, Harris LS, Dewey WL, Razdan RK. Pharmacological potency of R- and S-3'-hydroxy-delta 9-tetrahydrocannabinol: additional structural requirement for cannabinoid activity. Pharmacology, Biochemistry, and Behavior. 21: 61-5. PMID 6087379 DOI: 10.1016/0091-3057(84)90131-X  0.648
1983 Rosin DL, Martin BR. Comparison of the effects of acute and subchronic administration of aroclor 1254, a commercial mixture of polychlorinated biphenyls, on pentobarbital‐induced sleep time and [14c]pentobarbital disposition in mice Journal of Toxicology and Environmental Health. 11: 917-931. PMID 6413697 DOI: 10.1080/15287398309530395  0.311
1983 Harris LS, Aceto MD, Balster RL, Martin BR. Progress report: Medical College of Virginia--sigma agonists. Nida Research Monograph. 43: 79-84. PMID 6308455  0.406
1983 Freeman AS, Martin BR. Interactions between phencyclidine and delta 9-tetrahydrocannabinol in mice following smoke exposure. Life Sciences. 32: 1081-9. PMID 6298542 DOI: 10.1016/0024-3205(83)90113-3  0.377
1983 Aceto MD, Awaya H, Martin BR, May EL. Antinociceptive action of nicotine and its methiodide derivatives in mice and rats. British Journal of Pharmacology. 79: 869-76. PMID 6140048 DOI: 10.1111/J.1476-5381.1983.Tb10531.X  0.317
1983 Dewey WL, Bowman E, Jones D, Kachur J, Rosemond R, Welch S, Martin BR. Pharmachology The appearance of endogenous opiates in cerebrospinal fluid following opiate injection in various animal species Pain. 17: 393. DOI: 10.1016/0304-3959(83)90171-9  0.488
1982 Dewey WL, Bowman E, Jones D, Kachur J, Rosemond R, Welch S, Martin BR. The appearance of endogenous opiates in cerebrospinal fluid following opiate injection in various animal species. Life Sciences. 31: 1741-3. PMID 7154834 DOI: 10.1016/0024-3205(82)90199-0  0.554
1982 Handrick GR, Duffley RP, Lambert G, Murphy JG, Dalzell HC, Howes JF, Razdan RK, Martin BR, Harris LS, Dewey WL. 3'-Hydroxy- and (+/-)-3',11-dihydroxy-delta 9-tetrahydrocannabinol: biologically active metabolites of delta 9-tetrahydrocannabinol. Journal of Medicinal Chemistry. 25: 1447-50. PMID 6296389  0.629
1982 Dewey WL, Fu TC, Ohlsson A, Bowman E, Martin BR. Evidence for the release of endogenous opiates by morphine. Nida Research Monograph. 41: 60-6. PMID 6289120  0.422
1982 Ohlsson AE, Fu TC, Jones D, Martin BR, Dewey WL. Distribution of radioactivity in the spinal cord after intracerebroventricular and intravenous injection of radiolabeled opioid peptides in mice. The Journal of Pharmacology and Experimental Therapeutics. 221: 362-7. PMID 6281413  0.45
1981 Vincek WC, Martin BR, Aceto MD, Tripathi HL, May EL, Harris LS. Synthesis of 4,4-ditritio-(+)-nicotine: comparative binding and distribution studies with natural enantiomer. Journal of Pharmaceutical Sciences. 70: 1292-3. PMID 7299682 DOI: 10.1002/JPS.2600701131  0.523
1981 Martin BR, Aceto MD. Nicotine binding sites and their localization in the central nervous system Neuroscience & Biobehavioral Reviews. 5: 473-478. PMID 7033844 DOI: 10.1016/0149-7634(81)90017-8  0.303
1981 Martin BR, Balster RL, Razdan RK, Harris LS, Dewey WL. Behavioral comparisons of the stereoisomers of tetrahydrocannabinols. Life Sciences. 29: 565-74. PMID 6268916 DOI: 10.1016/0024-3205(81)90434-3  0.632
1980 Vincek WC, Martin BR, Aceto MD, Bowman ER. Synthesis and preliminary binding studies of 4,4-ditritio-(-)-nicotine of high specific activity. Journal of Medicinal Chemistry. 23: 960-962. PMID 7401120 DOI: 10.1021/Jm00182A028  0.304
1980 Woolverton WL, Martin BR, Balster RL. Modification of the behavioral effects of phencyclidine by repeated drug exposure and body weight changes. Pharmacology, Biochemistry, and Behavior. 12: 761-6. PMID 7393970 DOI: 10.1016/0091-3057(80)90163-X  0.309
1980 Man M, Harris LS, Woods LA, Martin BR. Isotope dilution technique for the estimation of l-alpha-[2-3H]-acetylmethadol and its metabolites in biological samples. Pharmacology. 20: 130-6. PMID 6992151  0.391
1980 Alozie SO, Martin BR, Harris LS, Dewey WL. 3H-delta 9-Tetrahydrocannabinol, 3H-cannabinol and 3H-cannabidiol: penetration and regional distribution in rat brain. Pharmacology, Biochemistry, and Behavior. 12: 217-21. PMID 6246544 DOI: 10.1016/0091-3057(80)90359-7  0.612
1980 Man M, Alozie SO, Woods LA, Martin BR, Harris LS. Distribution of l-alpha-[2-3H]acetylmethadol and its metabolites in maternal and fetal rat tissues. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 8: 55-9. PMID 6103787  0.391
1979 Wilson RS, Martin BR, Dewey WL. Some 11-substituted tetrahydrocannabinols. Synthesis and comparison with the potent cannabinoid metabolites 11-hydroxytetrahydrocannabinols. Journal of Medicinal Chemistry. 22: 879-82. PMID 448686 DOI: 10.1021/JM00193A025  0.557
1979 Aceto MD, Martin BR, Uwaydah IM, May EL, Harris LS, Izazola-Conde C, Dewey WL, Bradshaw TJ, Vincek WC. Optically pure (+)-nicotine from (+/-)-nicotine and biological comparisons with (-)-nicotine. Journal of Medicinal Chemistry. 22: 174-7. PMID 423195 DOI: 10.1021/JM00188A009  0.624
1979 Carney JM, Balster RL, Martin BR, Harris LS. Effects of systemic and intraventricular administration of cannabinoids on schedule-controlled responding in the squirrel monkey. The Journal of Pharmacology and Experimental Therapeutics. 210: 399-404. PMID 113528  0.492
1979 Toro-Goyco E, Martin BR, Harris LS. The binding of LAAM and its metabolites to blood constituents. Nida Research Monograph. 27: 54-60. PMID 95037  0.393
1978 Harris LS, Carchman RA, Martin BR. Evidence for the existence of specific cannabinoid binding sites. Life Sciences. 22: 1131-7. PMID 661500 DOI: 10.1016/0024-3205(78)90082-6  0.49
1978 Martin BR, Montgomery J, Dewey WL, Harris LS. Alterations in the pharmacokinetics of 3H-delta9-tetrahydrocannabinol in mice by bacterial endotoxin. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 6: 282-7. PMID 26549  0.625
1977 Martin BR, Dewey WL, Harris LS, Beckner JS. 3H-delta9-tetrahydrocannabinol distribution in pregnant dogs and their fetuses. Research Communications in Chemical Pathology and Pharmacology. 17: 457-70. PMID 897339  0.564
1977 Adams MD, Earnhardt JT, Martin BR, Harris LS, Dewey WL, Razdan RK. A cannabinoid with cardiovascular activity but no overt behavioral effects. Experientia. 33: 1204-5. PMID 891878 DOI: 10.1007/Bf01922330  0.634
1977 Martin BR, Dewey WL, Aceto MD, Adams MD, Earnhardt JT, Carney JM. A potent antinociceptive cannabinoid which lacks opiate substitution properties in monkeys. Research Communications in Chemical Pathology and Pharmacology. 16: 187-90. PMID 402685  0.472
1977 Martin BR, Dewey WL, Chau-Pham T, Prnage AJ. Interactions of thyrotropin releasing hormone and morphine sulfate in rodents. Life Sciences. 20: 715-22. PMID 402526 DOI: 10.1016/0024-3205(77)90477-5  0.539
1976 Martin BR, Dewey WL, Harris LS, Beckner JS. 3H-delta9-tetrahydrocannabinol tissue and subcellular distribution in the central nervous system and tissue distribution in peripheral organs of tolerant and nontolerant dogs. The Journal of Pharmacology and Experimental Therapeutics. 196: 128-44. PMID 1246007  0.575
1976 Wilson RS, May EL, Martin BR, Dewey WL. 9 Nor 9 hydroxyhexahydrocannabinols. Synthesis, some behavioral and analgesic properties, and comparison with the tetrahydrocannabinols Journal of Medicinal Chemistry. 19: 1165-1167. PMID 978681 DOI: 10.1002/Chin.197652236  0.538
1975 Martin BR, Dewey WL, Harris LS, Beckner J. Marihuana-like activity of new synthetic tetrahydrocannabinols. Pharmacology, Biochemistry, and Behavior. 3: 849-53. PMID 1208625 DOI: 10.1016/0091-3057(75)90116-1  0.672
Low-probability matches (unlikely to be authored by this person)
1989 Hutchings DE, Martin BR, Gamagaris Z, Miller N, Fico T. Plasma concentrations of delta-9-tetrahydrocannabinol in dams and fetuses following acute or multiple prenatal dosing in rats. Life Sciences. 44: 697-701. PMID 2538691 DOI: 10.1016/0024-3205(89)90380-9  0.3
1991 Darmani NA, Saady JJ, Schnoll SH, Martin BR. Demonstration of physical dependence following chronic continuous methadone delivery via osmotic minipumps in pregnant rats. Neurotoxicology and Teratology. 13: 627-630. PMID 1779950 DOI: 10.1016/0892-0362(91)90046-Y  0.297
1982 Holsapple MP, Munson AE, Freeman AS, Martin BR. Pharmacological activity and toxicity of phencyclidine (PCP) and phenylcyclohexene (PC), a pyrolysis product. Life Sciences. 31: 803-13. PMID 7132580 DOI: 10.1016/0024-3205(82)90708-1  0.295
2005 Carroll FI, Ma W, Yokota Y, Lee JR, Brieaddy LE, Navarro HA, Damaj MI, Martin BR. Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 3'-substituted deschloroepibatidine analogues. Novel nicotinic antagonists. Journal of Medicinal Chemistry. 48: 1221-8. PMID 15715488 DOI: 10.1021/jm040160b  0.295
1987 Compton DR, Bagley RB, Katzen JS, Martin BR. (+)- and (-)-N-allylnormetazocine binding sites in mouse brain: in vitro and in vivo characterization and regional distribution. Life Sciences. 40: 2195-206. PMID 3035304 DOI: 10.1016/0024-3205(87)90011-7  0.294
1999 Damaj MI, Glassco W, Aceto MD, Martin BR. Antinociceptive and pharmacological effects of metanicotine, a selective nicotinic agonist. The Journal of Pharmacology and Experimental Therapeutics. 291: 390-8. PMID 10490929  0.293
1996 Compton DR, Aceto MD, Lowe J, Martin BR. In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity. The Journal of Pharmacology and Experimental Therapeutics. 277: 586-94. PMID 8627535  0.293
1986 Little PJ, Reynolds ML, Bowman ER, Martin BR. Tissue disposition of [3H]sarin and its metabolites in mice. Toxicology and Applied Pharmacology. 83: 412-419. PMID 3705071 DOI: 10.1016/0041-008X(86)90223-1  0.293
1994 Smith PB, Welch SP, Martin BR. Interactions between delta 9-tetrahydrocannabinol and kappa opioids in mice. The Journal of Pharmacology and Experimental Therapeutics. 268: 1381-7. PMID 8138952  0.292
1996 Showalter VM, Compton DR, Martin BR, Abood ME. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands. The Journal of Pharmacology and Experimental Therapeutics. 278: 989-99. PMID 8819477  0.292
2008 Raborn ES, Marciano-Cabral F, Buckley NE, Martin BR, Cabral GA. The cannabinoid delta-9-tetrahydrocannabinol mediates inhibition of macrophage chemotaxis to RANTES/CCL5: linkage to the CB2 receptor. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 3: 117-29. PMID 18247131 DOI: 10.1007/S11481-007-9077-Z  0.29
1981 Vincek WC, Martin BR, Aceto MD, Bowman ER. Synthesis And Preliminary Binding Studies Of 4,4-Ditritio-(-)-Nicotine Of High Specific Activity Cheminform. 12. DOI: 10.1002/Chin.198105184  0.29
2002 Martin BR. Cannabis produces dependence: a comment on Smith. Addiction (Abingdon, England). 97: 754-5. PMID 12084146 DOI: 10.1046/J.1360-0443.2002.T01-1-00060.X  0.289
1985 Scimeca JA, Little PJ, Martin BR. Relationship between the pharmacological effects and the biodisposition of [3H]diisopropylfluorophosphate in mice after inhalation. Toxicology and Applied Pharmacology. 79: 502-510. PMID 4035691 DOI: 10.1016/0041-008X(85)90147-4  0.288
2002 Martin BR. Identification of the endogenous cannabinoid system through integrative pharmacological approaches. The Journal of Pharmacology and Experimental Therapeutics. 301: 790-6. PMID 12023505 DOI: 10.1124/Jpet.301.3.790  0.285
2006 Damaj MI, Zheng J, Martin BR, Kuhar MJ. Intrathecal CART (55-102) attenuates hyperlagesia and allodynia in a mouse model of neuropathic but not inflammatory pain. Peptides. 27: 2019-23. PMID 16814901 DOI: 10.1016/J.Peptides.2005.09.019  0.285
1987 Little PJ, Kaplan NC, Martin BR. Pharmacological profile of delta 9-THC carbamate. Alcohol and Drug Research. 7: 517-23. PMID 3040025  0.285
2001 Selley DE, Rorrer WK, Breivogel CS, Zimmer AM, Zimmer A, Martin BR, Sim-Selley LJ. Agonist efficacy and receptor efficiency in heterozygous CB1 knockout mice: relationship of reduced CB1 receptor density to G-protein activation. Journal of Neurochemistry. 77: 1048-57. PMID 11359870 DOI: 10.1046/J.1471-4159.2001.00308.X  0.283
1998 Griffin G, Atkinson PJ, Showalter VM, Martin BR, Abood ME. Evaluation of cannabinoid receptor agonists and antagonists using the guanosine-5'-O-(3-[35S]thio)-triphosphate binding assay in rat cerebellar membranes. The Journal of Pharmacology and Experimental Therapeutics. 285: 553-60. PMID 9580597  0.283
1985 Martin BR. Biodisposition of [3H]diisopropylfluorophosphate in mice. Toxicology and Applied Pharmacology. 77: 275-284. PMID 3975900 DOI: 10.1016/0041-008X(85)90327-8  0.282
1990 Martin TJ, Suchocki J, May EL, Martin BR. Pharmacological evaluation of the antagonism of nicotine's central effects by mecamylamine and pempidine. The Journal of Pharmacology and Experimental Therapeutics. 254: 45-51. PMID 2366189  0.282
2000 Dasse O, Mahadevan A, Han L, Martin BR, Marzo VD, Razdan RK. The Synthesis of N-Vanillyl-arachidonoyl-amide (Arvanil) and its Analogs: An Improved Procedure for the Synthesis of the Key Synthon Methyl 14-Hydroxy-(all-cis)-5,8,11-tetradecatrienoate Tetrahedron. 56: 9195-9202. DOI: 10.1016/S0040-4020(00)00877-2  0.28
1982 Bowman ER, McKennis H, Martin BR. A Convenient Method for the Preparation of Racemic Nicotine Synthetic Communications. 12: 871-879. DOI: 10.1080/00397918208065965  0.28
2007 Falenski KW, Blair RE, Sim-Selley LJ, Martin BR, DeLorenzo RJ. Status epilepticus causes a long-lasting redistribution of hippocampal cannabinoid type 1 receptor expression and function in the rat pilocarpine model of acquired epilepsy. Neuroscience. 146: 1232-44. PMID 17433556 DOI: 10.1016/J.Neuroscience.2007.01.065  0.275
1998 Damaj MI, Fei-Yin M, Dukat M, Glassco W, Glennon RA, Martin BR. Antinociceptive responses to nicotinic acetylcholine receptor ligands after systemic and intrathecal administration in mice. The Journal of Pharmacology and Experimental Therapeutics. 284: 1058-65. PMID 9495867  0.272
1997 Damaj MI, Glassco W, Marks MJ, Slobe B, James JR, May EL, Rosecrans JA, Collins AC, Martin BR. Pharmacological investigation of (+)- and (-)-cis-2,3,3a,4,5,9b-hexahydro-1-methyl-1H-pyrrolo-[3,2-h]isoq uinoline, a bridged-nicotine analog. The Journal of Pharmacology and Experimental Therapeutics. 282: 1425-34. PMID 9316856  0.271
1999 Martin BR, Mechoulam R, Razdan RK. Discovery and characterization of endogenous cannabinoids. Life Sciences. 65: 573-95. PMID 10462059 DOI: 10.1016/S0024-3205(99)00281-7  0.27
1982 Tripathi HL, Martin BR, Aceto MD. Nicotine-induced antinociception in rats and mice: correlation with nicotine brain levels. The Journal of Pharmacology and Experimental Therapeutics. 221: 91-6. PMID 7062295  0.269
1986 Lue LP, Scimeca JA, Thomas BF, Martin BR. Identification and quantification of phencyclidine pyrolysis products formed during smoking. Journal of Analytical Toxicology. 10: 81-6. PMID 3724075 DOI: 10.1093/Jat/10.3.81  0.269
2005 Damaj MI, Flood P, Ho KK, May EL, Martin BR. Effect of dextrometorphan and dextrorphan on nicotine and neuronal nicotinic receptors: in vitro and in vivo selectivity. The Journal of Pharmacology and Experimental Therapeutics. 312: 780-5. PMID 15356218 DOI: 10.1124/Jpet.104.075093  0.268
1986 Martin BR. Cellular effects of cannabinoids. Pharmacological Reviews. 38: 45-74. PMID 2872689  0.267
1981 Freeman AS, Martin BR. Quantification of phencyclidine in mainstream smoke and identification of phenylcyclohex-1-ene as pyrolysis product. Journal of Pharmaceutical Sciences. 70: 1002-4. PMID 6101140 DOI: 10.1002/Jps.2600700908  0.267
2002 Dukat M, Damaj IM, Young R, Vann R, Collins AC, Marks MJ, Martin BR, Glennon RA. Functional diversity among 5-substituted nicotine analogs; in vitro and in vivo investigations. European Journal of Pharmacology. 435: 171-80. PMID 11821023 DOI: 10.1016/S0014-2999(01)01570-9  0.266
1995 Lainton JAH, Huffman JW, Martin BR, Compton DR. 1-Alkyl-3-(1-naphthoyl)pyrroles: A new class of cannabinoid Tetrahedron Letters. 36: 1401-1404. DOI: 10.1016/0040-4039(95)00016-6  0.264
1992 Martin BR, Prescott WR, Zhu M. Quantitation of rodent catalepsy by a computer-imaging technique. Pharmacology, Biochemistry and Behavior. 43: 381-386. PMID 1332079 DOI: 10.1016/0091-3057(92)90166-D  0.264
1982 Aceto MD, Martin BR. Central actions of nicotine Medicinal Research Reviews. 2: 43-62. PMID 6125634 DOI: 10.1002/Med.2610020104  0.263
2007 Rock RB, Gekker G, Hu S, Sheng WS, Cabral GA, Martin BR, Peterson PK. WIN55,212-2-mediated inhibition of HIV-1 expression in microglial cells: involvement of cannabinoid receptors. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 2: 178-83. PMID 18040842 DOI: 10.1007/S11481-006-9040-4  0.263
2005 Martin BR. Role of lipids and lipid signaling in the development of cannabinoid tolerance. Life Sciences. 77: 1543-58. PMID 15949820 DOI: 10.1016/j.lfs.2005.05.005  0.262
1997 Budney AJ, Kandel DB, Cherek DR, Martin BR, Stephens RS, Roffman R. College on problems of drug dependence meeting, Puerto Rico (June 1996) marijuana use and dependence. Drug and Alcohol Dependence. 45: 1-11. PMID 9179501 DOI: 10.1016/S0376-8716(97)01351-3  0.259
1991 Reggio PH, McGaughey GB, Odear DF, Seltzman HH, Compton DR, Martin BR. A rational search for the separation of psychoactivity and analgesia in cannabinoids. Pharmacology, Biochemistry, and Behavior. 40: 479-86. PMID 1806940 DOI: 10.1016/0091-3057(91)90350-B  0.257
1995 Huffman JW, Kenneth Banner W, Zoorob GK, Howard Joyner H, Reggio PH, Martin BR, Compton DR. Stereoselective synthesis of the epimeric Δ7-tetrahydrocannabinols Tetrahedron. 51: 1017-1032. DOI: 10.1016/0040-4020(94)00995-7  0.257
1989 Martin BR, Lue LP, Boni JP. Pyrolysis and Volatilization of Cocaine Journal of Analytical Toxicology. 13: 158-162. PMID 2755088 DOI: 10.1093/Jat/13.3.158  0.257
2000 Pertwee RG, Gibson TM, Stevenson LA, Ross RA, Banner WK, Saha B, Razdan RK, Martin BR. O-1057, a potent water-soluble cannabinoid receptor agonist with antinociceptive properties. British Journal of Pharmacology. 129: 1577-84. PMID 10780961 DOI: 10.1038/Sj.Bjp.0703245  0.256
1989 Martin BR, Onaivi ES, Martin TJ. What is the nature of mecamylamine's antagonism of the central effects of nicotine? Biochemical Pharmacology. 38: 3391-3397. PMID 2684166 DOI: 10.1016/0006-2952(89)90106-8  0.256
1992 Kaminski NE, Abood ME, Kessler FK, Martin BR, Schatz AR. Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation Molecular Pharmacology. 42: 736-742. PMID 1279376  0.253
1988 Lue LP, Scimeca JA, Thomas BF, Martin BR. Pyrolytic fate of piperidinocyclohexanecarbonitrile, a contaminant of phencyclidine, during smoking. Journal of Analytical Toxicology. 12: 57-61. PMID 3379921 DOI: 10.1093/Jat/12.2.57  0.253
2002 Wallace MJ, Martin BR, DeLorenzo RJ. Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity. European Journal of Pharmacology. 452: 295-301. PMID 12359270 DOI: 10.1016/S0014-2999(02)02331-2  0.25
1992 Darmani NA, Martin BR, Glennon RA. Behavioral evidence for differential adaptation of the serotonergic system after acute and chronic treatment with (+/- )-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) or ketanserin. The Journal of Pharmacology and Experimental Therapeutics. 262: 692-8. PMID 1501117  0.246
2002 Ferretti G, Dukat M, Giannella M, Piergentili A, Pigini M, Quaglia W, Damaj MI, Martin BR, Glennon RA. Homoazanicotine: a structure-affinity study for nicotinic acetylcholine (nACh) receptor binding. Journal of Medicinal Chemistry. 45: 4724-31. PMID 12361399 DOI: 10.1021/Jm020188S  0.245
2001 Carroll FI, Liang F, Navarro HA, Brieaddy LE, Abraham P, Damaj MI, Martin BR. Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2'-substituted 5'-pyridinyl)-7-azabicyclo[2.2.1]heptanes. Epibatidine analogues. Journal of Medicinal Chemistry. 44: 2229-37. PMID 11405659 DOI: 10.1021/jm0100178  0.244
2001 Brieaddy LE, Wayne Mascarella S, Navarro HA, Atkinson RN, Damaj M, Martin BR, Carroll F. Synthesis of bridged analogs of epibatidine. 3-Chloro-5,7,8,9,9a,10-hexahydro-7,10-methanopyrrolo[1,2-b]-2,6-naphthyridine and 2-chloro-5,5a,6,7,8,10-hexahydro-5,8-methanopyrrolo[2,1-b]-1,7-naphthyridine Tetrahedron Letters. 42: 3795-3797. DOI: 10.1016/S0040-4039(01)00575-5  0.243
1992 Compton DR, Gold LH, Ward SJ, Balster RL, Martin BR. Aminoalkylindole analogs: cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinol. The Journal of Pharmacology and Experimental Therapeutics. 263: 1118-26. PMID 1335057  0.24
2007 Damaj MI, Fonck C, Marks MJ, Deshpande P, Labarca C, Lester HA, Collins AC, Martin BR. Genetic approaches identify differential roles for alpha4beta2* nicotinic receptors in acute models of antinociception in mice. The Journal of Pharmacology and Experimental Therapeutics. 321: 1161-9. PMID 17371806 DOI: 10.1124/jpet.106.112649  0.24
1991 Martin BR, Compton DR, Thomas BF, Prescott WR, Little PJ, Razdan RK, Johnson MR, Melvin LS, Mechoulam R, Ward SJ. Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs. Pharmacology, Biochemistry, and Behavior. 40: 471-8. PMID 1666911 DOI: 10.1016/0091-3057(91)90349-7  0.24
1999 Damaj MI, Slemmer JE, Carroll FI, Martin BR. Pharmacological characterization of nicotine's interaction with cocaine and cocaine analogs. The Journal of Pharmacology and Experimental Therapeutics. 289: 1229-36. PMID 10336510  0.239
1996 Aceto MD, Scates SM, Lowe JA, Martin BR. Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A. European Journal of Pharmacology. 282: R1-2. PMID 7498260 DOI: 10.1016/0014-2999(95)00447-S  0.238
2009 Blair RE, Deshpande LS, Sombati S, Elphick MR, Martin BR, DeLorenzo RJ. Prolonged exposure to WIN55,212-2 causes downregulation of the CB1 receptor and the development of tolerance to its anticonvulsant effects in the hippocampal neuronal culture model of acquired epilepsy. Neuropharmacology. 57: 208-18. PMID 19540252 DOI: 10.1016/J.Neuropharm.2009.06.007  0.236
1992 Abood ME, Martin BR. Neurobiology of marijuana abuse Trends in Pharmacological Sciences. 13: 201-206. PMID 1604713 DOI: 10.1016/0165-6147(92)90064-D  0.235
2004 Dogruer D, Lee M, Dukat M, Damaj MI, Martin BR, Glennon RA. 3-(4-Aminobutyn-1-yl)pyridines: binding at alpha 4 beta 2 nicotinic cholinergic receptors. Bioorganic & Medicinal Chemistry Letters. 14: 523-6. PMID 14698195 DOI: 10.1016/J.Bmcl.2003.10.033  0.235
2009 Zhang M, Martin BR, Adler MW, Razdan RJ, Kong W, Ganea D, Tuma RF. Modulation of cannabinoid receptor activation as a neuroprotective strategy for EAE and stroke. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 4: 249-59. PMID 19255856 DOI: 10.1007/S11481-009-9148-4  0.235
2005 Grabus SD, Martin BR, Imad Damaj M. Nicotine physical dependence in the mouse: involvement of the alpha7 nicotinic receptor subtype. European Journal of Pharmacology. 515: 90-3. PMID 15896732 DOI: 10.1016/J.Ejphar.2005.03.044  0.234
1982 Rosin DL, Martin BR. Neurochemical and behavioral effects of polychlorinated biphenyls in mice. Neurotoxicology. 2: 749-64. PMID 6123098  0.234
2006 Walters CL, Brown S, Changeux JP, Martin B, Damaj MI. The beta2 but not alpha7 subunit of the nicotinic acetylcholine receptor is required for nicotine-conditioned place preference in mice. Psychopharmacology. 184: 339-44. PMID 16416156 DOI: 10.1007/S00213-005-0295-X  0.232
2005 Ramunno A, Dukat M, Lee M, Young R, El-Zahabi M, Damaj MI, Martin B, Glennon RA. 6-(2-Phenylethyl)nicotine: A novel nicotinic cholinergic receptor ligand Bioorganic and Medicinal Chemistry Letters. 15: 3237-3240. PMID 15925512 DOI: 10.1016/J.Bmcl.2005.04.072  0.23
1994 Smith PB, Compton DR, Welch SP, Razdan RK, Mechoulam R, Martin BR. The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice. The Journal of Pharmacology and Experimental Therapeutics. 270: 219-27. PMID 8035318  0.23
1999 Di Marzo V, Bisogno T, De Petrocellis L, Melck D, Martin BR. Cannabimimetic fatty acid derivatives: the anandamide family and other endocannabinoids. Current Medicinal Chemistry. 6: 721-44. PMID 10469888  0.23
2008 Zhang M, Martin BR, Adler MW, Razdan RK, Ganea D, Tuma RF. Modulation of the balance between cannabinoid CB(1) and CB(2) receptor activation during cerebral ischemic/reperfusion injury. Neuroscience. 152: 753-60. PMID 18304750 DOI: 10.1016/J.Neuroscience.2008.01.022  0.229
1982 Martin BR. GC/MS Assays for Abused Drugs in Body Fluid. NIDA Research Monograph 32. By Rodger L. Foltz, Allison F. Fentiman, and Ruth B. Foltz. National Institute on Drug Abuse, Division of Research, 5600 Fishers Lane, Rockville, MD 20857. 1980. 202 pp. 14 × 23 cm. Price $5.00. (Available from Superintendent of Documents, U.S. Government Printing Office, Washington, DC 20402. Specify GPO stock no. 017-024-01015-4.) Journal of Pharmaceutical Sciences. 71: 133-134. DOI: 10.1002/Jps.2600710141  0.229
1996 Aceto MD, Scates SM, Lowe JA, Martin BR. Dependence on delta 9-tetrahydrocannabinol: studies on precipitated and abrupt withdrawal. The Journal of Pharmacology and Experimental Therapeutics. 278: 1290-5. PMID 8819514  0.229
1990 Compton DR, Prescott WR, Siegel CS, Gordon PM, Razdan RK, Martin BR. Evaluation of ether and free hydroxyl analogs of delta-8, delta-9, 11-THC as cannabinoid antagonists. Nida Research Monograph. 105: 297-8. PMID 1652071  0.229
2009 Jackson KJ, Kota DH, Martin BR, Damaj MI. The role of various nicotinic receptor subunits and factors influencing nicotine conditioned place aversion. Neuropharmacology. 56: 970-4. PMID 19371584 DOI: 10.1016/J.Neuropharm.2009.01.023  0.227
1996 Damaj MI, Welch SP, Martin BR. Characterization and modulation of acute tolerance to nicotine in mice. The Journal of Pharmacology and Experimental Therapeutics. 277: 454-61. PMID 8613954  0.227
1992 Gold LH, Balster RL, Barrett RL, Britt DT, Martin BR. A comparison of the discriminative stimulus properties of delta 9-tetrahydrocannabinol and CP 55,940 in rats and rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 262: 479-86. PMID 1323651  0.225
1987 Martin BR, Compton DR, Little PJ, Martin TJ, Beardsley PM. Pharmacological evaluation of agonistic and antagonistic activity of cannabinoids. Nida Research Monograph. 79: 108-22. PMID 2830532  0.225
1991 Charalambous A, Lin S, Marciniak G, Banijamali A, Friend FL, Compton DR, Martin BR, Makriyannis A. Pharmacological evaluation of halogenated delta 8-THC analogs. Pharmacology, Biochemistry, and Behavior. 40: 509-12. PMID 1666915 DOI: 10.1016/0091-3057(91)90355-6  0.222
1998 Aceto MD, Scates SM, Razdan RK, Martin BR. Anandamide, an endogenous cannabinoid, has a very low physical dependence potential. The Journal of Pharmacology and Experimental Therapeutics. 287: 598-605. PMID 9808686  0.221
1999 Kunos G, Jarai Z, Wagner JA, Compton DR, Martin BR, Zimmer AM, Bonner TI, Razdan RK, Zimmer A. SHJ+ anandamide induces nitric oxide-independent mesenteric vasodilation via a novel endothelial site of action Prostaglandins & Other Lipid Mediators. 59: 52. DOI: 10.1016/S0090-6980(99)90287-3  0.22
2000 Martin BR, Beletskaya I, Patrick G, Jefferson R, Winckler R, Deutsch DG, Di Marzo V, Dasse O, Mahadevan A, Razdan RK. Cannabinoid properties of methylfluorophosphonate analogs. The Journal of Pharmacology and Experimental Therapeutics. 294: 1209-18. PMID 10945879  0.22
1991 Thomas BF, Compton DR, Martin BR, Semus SF. Modeling the cannabinoid receptor: a three-dimensional quantitative structure-activity analysis. Molecular Pharmacology. 40: 656-65. PMID 1944237  0.219
2005 Grabus SD, Martin BR, Batman AM, Tyndale RF, Sellers E, Damaj MI. Nicotine physical dependence and tolerance in the mouse following chronic oral administration. Psychopharmacology. 178: 183-92. PMID 15365686 DOI: 10.1007/S00213-004-2007-3  0.216
2007 Damaj MI, Siu EC, Sellers EM, Tyndale RF, Martin BR. Inhibition of nicotine metabolism by methoxysalen: Pharmacokinetic and pharmacological studies in mice. The Journal of Pharmacology and Experimental Therapeutics. 320: 250-7. PMID 17021260 DOI: 10.1124/Jpet.106.111237  0.216
2009 Falenski KW, Carter DS, Harrison AJ, Martin BR, Blair RE, DeLorenzo RJ. Temporal characterization of changes in hippocampal cannabinoid CB(1) receptor expression following pilocarpine-induced status epilepticus. Brain Research. 1262: 64-72. PMID 19368833 DOI: 10.1016/J.Brainres.2009.01.036  0.214
2004 Dukat M, Taroua M, Dahdouh A, Siripurapu U, Damaj MI, Martin BR, Glennon RA. (+/-)8-Amino-5,6,7,8-tetrahydroisoquinolines as novel antinociceptive agents. Bioorganic & Medicinal Chemistry Letters. 14: 3651-4. PMID 15203136 DOI: 10.1016/J.Bmcl.2004.05.020  0.213
2005 Dukat M, Ramunno A, Banzi R, Damaj MI, Martin B, Glennon RA. 3-(2-Aminoethyl)pyridine analogs as α4β2 nicotinic cholinergic receptor ligands Bioorganic and Medicinal Chemistry Letters. 15: 4308-4312. PMID 16039854 DOI: 10.1016/J.Bmcl.2005.06.053  0.212
1990 Darmani NA, Hadfield MG, Carter WH, Martin BR. Acute and chronic effects of cocaine on isolation-induced aggression in mice. Psychopharmacology. 102: 37-40. PMID 2392505 DOI: 10.1007/Bf02245741  0.212
2009 Jackson KJ, Walters CL, Miles MF, Martin BR, Damaj MI. Characterization of pharmacological and behavioral differences to nicotine in C57Bl/6 and DBA/2 mice. Neuropharmacology. 57: 347-55. PMID 19619563 DOI: 10.1016/J.Neuropharm.2009.07.020  0.212
2003 Ferretti G, Dukat M, Giannella M, Piergentili A, Pigini M, Quaglia W, Damaj MI, Martin BR, Glennon RA. Binding of nicotine and homoazanicotine analogues at neuronal nicotinic acetylcholinergic (nACh) receptors. Bioorganic & Medicinal Chemistry Letters. 13: 733-5. PMID 12639569 DOI: 10.1016/S0960-894X(02)01031-4  0.212
1986 Thomas BF, Lyddane JE, Martin BR. Modification of behavioral effects and biodisposition of phencyclidine in rats by ammonium chloride. The Journal of Pharmacology and Experimental Therapeutics. 239: 48-54. PMID 3761197  0.211
1991 Darmani NA, Martin BR, Glennon RA. Withdrawal from chronic treatment with (+/-)-DOI causes super-sensitivity to 5-HT2 receptor-induced head-twitch behaviour in mice. European Journal of Pharmacology. 186: 115-8. PMID 2282932 DOI: 10.1016/0014-2999(90)94066-7  0.208
1996 Thomas BF, Adams IB, Mascarella SW, Martin BR, Razdan RK. Structure-activity analysis of anandamide analogs: relationship to a cannabinoid pharmacophore. Journal of Medicinal Chemistry. 39: 471-9. PMID 8558515 DOI: 10.1021/jm9505167  0.208
1999 Damaj MI, Glassco W, Dukat M, Martin BR. Pharmacological characterization of nicotine-induced seizures in mice. The Journal of Pharmacology and Experimental Therapeutics. 291: 1284-91. PMID 10565853  0.208
2008 Jackson KJ, Martin BR, Changeux JP, Damaj MI. Differential role of nicotinic acetylcholine receptor subunits in physical and affective nicotine withdrawal signs. The Journal of Pharmacology and Experimental Therapeutics. 325: 302-12. PMID 18184829 DOI: 10.1124/Jpet.107.132977  0.207
2007 Kota D, Martin BR, Robinson SE, Damaj MI. Nicotine dependence and reward differ between adolescent and adult male mice. The Journal of Pharmacology and Experimental Therapeutics. 322: 399-407. PMID 17446302 DOI: 10.1124/Jpet.107.121616  0.207
2000 Narahashi T, Fenster CP, Quick MW, Lester RA, Marszalec W, Aistrup GL, Sattelle DB, Martin BR, Levin ED. Symposium overview: mechanism of action of nicotine on neuronal acetylcholine receptors, from molecule to behavior. Toxicological Sciences : An Official Journal of the Society of Toxicology. 57: 193-202. PMID 11006350 DOI: 10.1093/Toxsci/57.2.193  0.206
2008 Abdrakhmanova GR, Carroll FI, Damaj MI, Martin BR. 3'-Fluoro substitution in the pyridine ring of epibatidine improves selectivity and efficacy for alpha4beta2 versus alpha3beta4 nAChRs. Neuropharmacology. 55: 1287-92. PMID 18775444 DOI: 10.1016/j.neuropharm.2008.08.007  0.204
2007 Deshpande LS, Blair RE, Nagarkatti N, Sombati S, Martin BR, DeLorenzo RJ. Development of pharmacoresistance to benzodiazepines but not cannabinoids in the hippocampal neuronal culture model of status epilepticus. Experimental Neurology. 204: 705-13. PMID 17289026 DOI: 10.1016/J.Expneurol.2007.01.001  0.204
1993 Martin BR, Compton DR, Semus SF, Lin S, Marciniak G, Grzybowska J, Charalambous A, Makriyannis A. Pharmacological evaluation of iodo and nitro analogs of delta 8-THC and delta 9-THC. Pharmacology, Biochemistry, and Behavior. 46: 295-301. PMID 8265683 DOI: 10.1016/0091-3057(93)90356-X  0.203
1993 Compton DR, Rice KC, De Costa BR, Razdan RK, Melvin LS, Johnson MR, Martin BR. Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities. The Journal of Pharmacology and Experimental Therapeutics. 265: 218-26. PMID 8474008  0.202
1997 Willoughby KA, Moore SF, Martin BR, Ellis EF. The biodisposition and metabolism of anandamide in mice. The Journal of Pharmacology and Experimental Therapeutics. 282: 243-7. PMID 9223560  0.202
1988 Little PJ, Compton DR, Johnson MR, Melvin LS, Martin BR. Pharmacology and stereoselectivity of structurally novel cannabinoids in mice. The Journal of Pharmacology and Experimental Therapeutics. 247: 1046-51. PMID 2849657  0.201
1996 Adams IB, Martin BR. Cannabis: pharmacology and toxicology in animals and humans. Addiction (Abingdon, England). 91: 1585-614. PMID 8972919 DOI: 10.1046/J.1360-0443.1996.911115852.X  0.198
2003 Damaj MI, Kao W, Martin BR. Characterization of spontaneous and precipitated nicotine withdrawal in the mouse. The Journal of Pharmacology and Experimental Therapeutics. 307: 526-34. PMID 12970387 DOI: 10.1124/jpet.103.054908  0.195
2000 Slemmer JE, Martin BR, Damaj MI. Bupropion is a nicotinic antagonist. The Journal of Pharmacology and Experimental Therapeutics. 295: 321-7. PMID 10991997  0.194
1993 Damaj MI, Welch SP, Martin BR. Involvement of calcium and L-type channels in nicotine-induced antinociception. The Journal of Pharmacology and Experimental Therapeutics. 266: 1330-8. PMID 7690401  0.193
2007 Deshpande LS, Sombati S, Blair RE, Carter DS, Martin BR, DeLorenzo RJ. Cannabinoid CB1 receptor antagonists cause status epilepticus-like activity in the hippocampal neuronal culture model of acquired epilepsy. Neuroscience Letters. 411: 11-6. PMID 17110038 DOI: 10.1016/J.Neulet.2006.09.046  0.187
1979 Martin BR, Stein JM, Kennedy EL. A new structural model for the activation of adenylate cyclase by hormone receptors (guanine nucleotides/irradiation inactivation) Biochemical Journal. 184: 253-260. PMID 230831  0.184
1992 Thomas BF, Wei X, Martin BR. Characterization and autoradiographic localization of the cannabinoid binding site in rat brain using [3H]11-OH-delta 9-THC-DMH. The Journal of Pharmacology and Experimental Therapeutics. 263: 1383-90. PMID 1335065  0.183
1983 Martin BR, Tripathi HL, Aceto MD, May EL. Relationship of the biodisposition of the stereoisomers of nicotine in the central nervous system to their pharmacological actions. The Journal of Pharmacology and Experimental Therapeutics. 226: 157-63. PMID 6864536  0.183
2008 Kota D, Martin BR, Damaj MI. Age-dependent differences in nicotine reward and withdrawal in female mice. Psychopharmacology. 198: 201-10. PMID 18338157 DOI: 10.1007/S00213-008-1117-8  0.183
2007 Zhang M, Martin BR, Adler MW, Razdan RK, Jallo JI, Tuma RF. Cannabinoid CB(2) receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion model. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 27: 1387-96. PMID 17245417 DOI: 10.1038/Sj.Jcbfm.9600447  0.182
1990 Thomas BF, Compton DR, Martin BR. Characterization of the lipophilicity of natural and synthetic analogs of delta 9-tetrahydrocannabinol and its relationship to pharmacological potency. The Journal of Pharmacology and Experimental Therapeutics. 255: 624-30. PMID 2173751  0.181
1980 Martin BR, Vincek WC, Balster RL. Studies on the disposition of phencyclidine in mice. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 8: 49-54. PMID 6103786  0.18
2007 Deshpande LS, Blair RE, Ziobro JM, Sombati S, Martin BR, DeLorenzo RJ. Endocannabinoids block status epilepticus in cultured hippocampal neurons. European Journal of Pharmacology. 558: 52-9. PMID 17174949 DOI: 10.1016/J.Ejphar.2006.11.030  0.178
1988 Little PJ, Scimeca JA, Martin BR. Distribution of [3H]diisopropylfluorophosphate, [3H]soman, [3H]sarin, and their metabolites in mouse brain. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 16: 515-20. PMID 2903016  0.175
2000 Keimowitz AR, Martin BR, Razdan RK, Crocker PJ, Mascarella SW, Thomas BF. QSAR analysis of Delta(8)-THC analogues: relationship of side-chain conformation to cannabinoid receptor affinity and pharmacological potency. Journal of Medicinal Chemistry. 43: 59-70. PMID 10633038 DOI: 10.1021/jm9902281  0.175
2008 Perrotti LI, Weaver RR, Robison B, Renthal W, Maze I, Yazdani S, Elmore RG, Knapp DJ, Selley DE, Martin BR, Sim-Selley L, Bachtell RK, Self DW, Nestler EJ. Distinct patterns of DeltaFosB induction in brain by drugs of abuse. Synapse (New York, N.Y.). 62: 358-69. PMID 18293355 DOI: 10.1002/Syn.20500  0.165
2004 Ghafouri N, Tiger G, Razdan RK, Mahadevan A, Pertwee RG, Martin BR, Fowler CJ. Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2-arachidonoylglycerol. British Journal of Pharmacology. 143: 774-84. PMID 15492019 DOI: 10.1038/Sj.Bjp.0705948  0.165
1989 Martin TJ, Suchocki J, May EL, Martin BR. Structural requirements for nicotinic antagonists in the CNS. Nida Research Monograph. 95: 514-5. PMID 2641046  0.161
1983 Tolkovsky AM, Martin BR. The glucagon receptor from liver can be functionally fused to caudate nucleus adenylate cyclase. Febs Letters. 150: 337-42. PMID 6297980 DOI: 10.1016/0014-5793(82)80764-3  0.159
1982 Davis RJ, Martin BR. The effect of α-adrenergic agonists on the membrane potential of fat-cell mitochondria in situ Biochemical Journal. 206: 619-626. PMID 6128974  0.158
1990 Thomas BF, Martin BR. In vitro metabolism of (-)-cis-3-[2-hydroxy-4-(1,1-dimethylheptyl) phenyl]-trans-4-(3-hydroxypropyl) cyclohexanol, a synthetic bicyclic cannabinoid analog. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 18: 1046-54. PMID 1981511  0.156
1996 Bonfiglio MF, Fisher-Katz LE, Saltis LM, Traeger SM, Martin BR, Nackes NA, Perkins TA. A pilot pharmacokinetic-pharmacodynamic study of benzodiazepine antagonism by flumazenil and aminophylline. Pharmacotherapy. 16: 1166-72. PMID 8947991  0.155
1990 Gennings C, Carter WH, Campbell ED, Staniswalis JG, Martin TJ, Martin BR, White KL. Isobolographic characterization of drug interactions incorporating biological variability. The Journal of Pharmacology and Experimental Therapeutics. 252: 208-17. PMID 2299590  0.153
1984 Stein JM, Martin BR. The effect of carbacyclin, a prostaglandin analogue, on adenylate cyclase activity in platelet membranes. Febs Letters. 165: 290-2. PMID 6363123 DOI: 10.1016/0014-5793(84)80188-x  0.151
1991 Wadman IA, Farndale RW, Martin BR. Evidence for regulation of human platelet adenylate cyclase by phosphorylation. Inhibition by ATP and guanosine 5'-[beta-thio]diphosphate occur by distinct mechanisms. The Biochemical Journal. 621-30. PMID 1905923 DOI: 10.1042/Bj2760621  0.15
1982 Freeman AS, Martin BR. Disposition of phencyclidine in mice after smoke exposure. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 10: 680-4. PMID 6130923  0.15
1986 Wong SK, Martin BR, Tolkovsky AM. Pertussis toxin substrate is a guanosine 5'-[beta-thio]diphosphate-, N-ethylmaleimide-, Mg2+- and temperature-sensitive GTP-binding protein. The Biochemical Journal. 232: 191-7. PMID 3936483 DOI: 10.1042/bj2320191  0.149
1983 Martin BR, Freeman AS. Disposition of phencyclidine and its pyrolytic products in mice exposed to smoke. Federation Proceedings. 42: 2561-5. PMID 6852274  0.146
1977 Martin BR, Harvey DJ, Paton WD. Biotransformation of cannabidiol in mice. Identification of new acid metabolites. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 5: 259-67. PMID 17524  0.146
1985 Stein JM, Kornberg HL, Martin BR. Effects of GTP,GDP[beta S] and glucose on adenylate cyclase activity of E. coli B. Febs Letters. 182: 429-34. PMID 3884374 DOI: 10.1016/0014-5793(85)80348-3  0.142
1982 Martin BR. Long-term disposition of phencyclidine in mice. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 10: 189-93. PMID 6124408  0.142
1978 Harvey DJ, Martin BR, Paton WD. In vivo metabolism of cannabinol by the mouse and rat and a comparison with a metabolism of delta 1-tetrahydrocannabinol and cannabidiol. Biomedical Mass Spectrometry. 4: 364-70. PMID 597586 DOI: 10.1002/BMS.1200040608  0.141
1972 Prange AJ, Wilson IC, Knox AE, McClane TK, Breese GR, Martin BR, Alltop LB, Lipton MA. Thyroid-imipramine clinical and chemical interaction: evidence for a receptor deficit in depression. Journal of Psychiatric Research. 9: 187-205. PMID 5083174 DOI: 10.1016/0022-3956(72)90020-9  0.14
2005 Vandevoorde S, Saha B, Mahadevan A, Razdan RK, Pertwee RG, Martin BR, Fowler CJ. Influence of the degree of unsaturation of the acyl side chain upon the interaction of analogues of 1-arachidonoylglycerol with monoacylglycerol lipase and fatty acid amide hydrolase. Biochemical and Biophysical Research Communications. 337: 104-9. PMID 16181610 DOI: 10.1016/J.Bbrc.2005.09.015  0.14
1975 Prange AJ, Breese GR, Jahnke GD, Martin BR, Cooper BT, Cott JM, Wilson IC, Alltop LB, Lipton MA, Bissette G, Nemeroff CG, Loosen PT. Modification of pentobarbital effects by natural and synthetic polypeptides: dissociation of brain and pituitary effects. Life Sciences. 16: 1907-13. PMID 239299 DOI: 10.1016/0024-3205(75)90284-2  0.138
1997 Zafar TA, Weaver CM, Martin BR, Flarend R, Elmore D. Aluminum (26AI) metabolism in rats. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 216: 81-5. PMID 9316614 DOI: 10.3181/00379727-216-44159  0.138
1991 Boni JP, Barr WH, Martin BR. Cocaine inhalation in the rat: pharmacokinetics and cardiovascular response. The Journal of Pharmacology and Experimental Therapeutics. 257: 307-15. PMID 2019993  0.137
1989 Suchocki JA, Martin TJ, May EL, Martin BR. Synthesis of exo and endo mecamylamine analogs for nicotinic antagonism in the CNS. Nida Research Monograph. 95: 546-7. PMID 2641052  0.136
1981 Martin BR. Transient receptor coupling in the activation of rat liver plasma-membrane adenylate cyclase by glucagon. Biochemical Society Transactions. 9: 44-7. PMID 7215658 DOI: 10.1042/bst0090044  0.136
1985 Wong SK, Martin BR. The interactions between the activatory guanine nucleotide binding protein and the catalytic subunit of adenylate cyclase in rat liver plasma membranes. The Biochemical Journal. 231: 39-46. PMID 3933489 DOI: 10.1042/bj2310039  0.136
1982 Davis RJ, Martin BR. The effect of β-adrenergic agonists on the membrane potential of fat-cell mitochondria in situ Biochemical Journal. 206: 611-618. PMID 7150265  0.135
1992 Johansson EK, Tucker SM, Ginn HB, Martin BR, Aceto MD. Functional and dispositional tolerance develops during continuous cocaine exposure. European Journal of Drug Metabolism and Pharmacokinetics. 17: 155-62. PMID 1425814 DOI: 10.1007/BF03188784  0.133
2011 Adibekian A, Martin BR, Wang C, Hsu KL, Bachovchin DA, Niessen S, Hoover H, Cravatt BF. Click-generated triazole ureas as ultrapotent in vivo-active serine hydrolase inhibitors. Nature Chemical Biology. 7: 469-78. PMID 21572424 DOI: 10.1038/Nchembio.579  0.132
1995 Woodward JJ, Compton DM, Balster RL, Martin BR. In vitro and in vivo effects of cocaine and selected local anesthetics on the dopamine transporter European Journal of Pharmacology. 277: 7-13. PMID 7635175 DOI: 10.1016/0014-2999(95)00042-J  0.131
2019 Lisabeth EM, Kahl D, Gopallawa I, Haynes SE, Misek SA, Campbell PL, Dexheimer TS, Khanna D, Fox DA, Jin X, Martin BR, Larsen SD, Neubig RR. Identification of Pirin as a Molecular Target of the CCG-1423/CCG-203971 Series of Antifibrotic and Antimetastatic Compounds. Acs Pharmacology & Translational Science. 2: 92-100. PMID 32039344 DOI: 10.1021/acsptsci.8b00048  0.131
1982 Martin BR, Bailey BB, Awaya H, May EL, Narasimhachari N. In vitro metabolism of 1-phenyl-1-cyclohexene, a pyrolysis product of phencyclidine. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 10: 685-9. PMID 6130924  0.13
2009 Grider JR, Mahavadi S, Li Y, Qiao LY, Kuemmerle JF, Murthy KS, Martin BR. Modulation of motor and sensory pathways of the peristaltic reflex by cannabinoids. American Journal of Physiology. Gastrointestinal and Liver Physiology. 297: G539-49. PMID 19589944 DOI: 10.1152/Ajpgi.00064.2009  0.129
1984 Wong SK, Martin BR. The role of a guanine nucleotide-binding protein in the activation of rat liver plasma-membrane adenylate cyclase by forskolin. The Biochemical Journal. 216: 753-9. PMID 6320798 DOI: 10.1042/bj2160753  0.129
1986 Wong SK, Martin BR. Activation of rat liver adenylate cyclase by guanosine 5'-[beta,gamma-imido]triphosphate and glucagon. Existence of reversibly and irreversibly activated states of the stimulatory GTP-binding protein. The Biochemical Journal. 233: 845-51. PMID 3010941 DOI: 10.1042/bj2330845  0.129
1977 Harvey DJ, Martin BR, Paton WD. Identification of glucuronides as in vivo liver conjugates of seven cannabinoids and some of their hydroxy and acid metabolites. Research Communications in Chemical Pathology and Pharmacology. 16: 265-79. PMID 847285  0.126
2011 Aschengrau A, Weinberg JM, Janulewicz PA, Romano ME, Gallagher LG, Winter MR, Martin BR, Vieira VM, Webster TF, White RF, Ozonoff DM. Affinity for risky behaviors following prenatal and early childhood exposure to tetrachloroethylene (PCE)-contaminated drinking water: a retrospective cohort study. Environmental Health : a Global Access Science Source. 10: 102. PMID 22136431 DOI: 10.1186/1476-069X-10-102  0.122
2008 Ariefdjohan MW, Martin BR, Lachcik PJ, Weaver CM. Acute and chronic effects of honey and its carbohydrate constituents on calcium absorption in rats. Journal of Agricultural and Food Chemistry. 56: 2649-54. PMID 18361495 DOI: 10.1021/Jf073357W  0.122
2009 Legette LL, Martin BR, Shahnazari M, Lee WH, Helferich WG, Qian J, Waters DJ, Arabshahi A, Barnes S, Welch J, Bostwick DG, Weaver CM. Supplemental dietary racemic equol has modest benefits to bone but has mild uterotropic activity in ovariectomized rats. The Journal of Nutrition. 139: 1908-13. PMID 19710157 DOI: 10.3945/Jn.109.108225  0.12
1978 Martin BR, Voorheis HP, Kennedy EL. Adenylate cyclase in bloodstream forms of Trypanosoma (Trypanozoon) brucei sp Biochemical Journal. 175: 207-212. PMID 32875  0.118
1987 Biffen M, Martin BR. Polyphosphoinositide labeling in rat liver plasma membranes is reduced by preincubation with cholera toxin. The Journal of Biological Chemistry. 262: 7744-50. PMID 3034904  0.114
1982 Halldin MM, Widman M, V Bahr C, Lindgren JE, Martin BR. Identification of in vitro metabolites of delta 1-tetrahydrocannabinol formed by human livers. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 10: 297-301. PMID 6126323  0.114
1999 Weaver CM, Schulze DG, Peck LW, Magnusen HM, Martin BR, Gruenhagen SE. Phosphate-binding capacity of ferrihydrite versus calcium acetate in rats. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 34: 324-7. PMID 10430981 DOI: 10.1016/S0272-6386(99)70362-8  0.114
1980 Doberska CA, MacPherson AJ, Martin BR. Requirement for guanosine triphosphate for cholera-toxin-catalysed incorporation of adenosine diphosphate ribose into rat liver plasma membranes and for activation of adenylate cyclase. The Biochemical Journal. 186: 749-54. PMID 6446902 DOI: 10.1042/bj1860749  0.114
2012 Adibekian A, Martin BR, Chang JW, Hsu KL, Tsuboi K, Bachovchin DA, Speers AE, Brown SJ, Spicer T, Fernandez-Vega V, Ferguson J, Hodder PS, Rosen H, Cravatt BF. Confirming target engagement for reversible inhibitors in vivo by kinetically tuned activity-based probes. Journal of the American Chemical Society. 134: 10345-8. PMID 22690931 DOI: 10.1021/Ja303400U  0.113
1990 Biffen M, Martin BR. Inhibition of PI-kinase in rat liver membranes by F-. Cellular Signalling. 1: 283-7. PMID 2561945 DOI: 10.1016/0898-6568(89)90045-4  0.112
1990 Reggio PH, Seltzman HH, Compton DR, Prescott WR, Martin BR. Investigation of the role of the phenolic hydroxyl in cannabinoid activity. Molecular Pharmacology. 38: 854-62. PMID 2174506  0.112
1991 Prescott WR, Martin BR. The evaluation of synthetic cannabimimetic congeners for discriminative stimulus and cataleptogenic effects in rats. Nida Research Monograph. 105: 421. PMID 1652087  0.11
1983 Stein JM, Martin BR. The role of GTP in prostaglandin E1 stimulation of adenylate cyclase in platelet membranes. The Biochemical Journal. 214: 231-4. PMID 6684425 DOI: 10.1042/bj2140231  0.11
1992 Farndale RW, Winkler AB, Martin BR, Barnes MJ. Inhibition of human platelet adenylate cyclase by collagen fibres. Effect of collagen is additive with that of adrenaline, but interactive with that of thrombin Biochemical Journal. 282: 25-32. PMID 1311555 DOI: 10.1042/Bj2820025  0.109
2016 Won SJ, Davda D, Labby KJ, Hwang SY, Pricer RE, Majmudar JD, Armacost KA, Rodriguez LA, Rodriguez CL, Chong FS, Torossian KA, Palakurthi J, Hur ES, Meagher JL, Brooks CL, ... Martin BR, et al. Molecular mechanism for isoform-selective inhibition of acyl protein thioesterases 1 and 2 (APT1 and APT2). Acs Chemical Biology. PMID 27748579 DOI: 10.1021/Acschembio.6B00720  0.108
1987 Farndale RW, Wong SK, Martin BR. Activation of adenylate cyclase in human platelet membranes by guanosine 5'-[beta gamma-imido]triphosphate is inhibited by cyclic-AMP-dependent phosphorylation. Slow activation occurs in the absence of ATP. The Biochemical Journal. 242: 637-43. PMID 3036096 DOI: 10.1042/BJ2420637  0.107
1980 Harvey DJ, Martin BR, Paton WDM. Identification of in vivo liver metabolites of Δ1-tetrahydrocannabinol, cannabidiol, and cannabinol produced by the guinea-pig Journal of Pharmacy and Pharmacology. 32: 267-271. PMID 6103056 DOI: 10.1111/j.2042-7158.1980.tb12910.x  0.107
2015 Xu H, Majmudar JD, Davda D, Ghanakota P, Kim KH, Carlson HA, Showalter HD, Martin BR, Amidon GL. Substrate-Competitive Activity-Based Profiling of Ester Prodrug Activating Enzymes. Molecular Pharmaceutics. 12: 3399-407. PMID 26262434 DOI: 10.1021/Acs.Molpharmaceut.5B00414  0.107
1982 Martin BR, Vincek WC, Balster RL. Synthesis and behavioral activity of cis-4-phenyl, 4-piperidinocyclohexanol, a metabolite of phencyclidine. Substance and Alcohol Actions/Misuse. 2: 143-7. PMID 7313923  0.106
1977 Harvey DJ, Martin BR, Paton WDM. Identification of di and tri substituted hydroxy and ketone metabolites of Δ1 tetrahydrocannabinol in mouse liver Journal of Pharmacy and Pharmacology. 29: 482-486. PMID 19597 DOI: 10.1111/j.2042-7158.1977.tb11373.x  0.105
1992 Compton DR, Johnson MR, Melvin LS, Martin BR. Pharmacological profile of a series of bicyclic cannabinoid analogs: classification as cannabimimetic agents. The Journal of Pharmacology and Experimental Therapeutics. 260: 201-9. PMID 1309872  0.103
2014 Stevenson S, Rottinger KA, Fahim M, Field JS, Martin BR, Arvola KD. Tuning the selectivity of Gd3N cluster endohedral metallofullerene reactions with Lewis acids. Inorganic Chemistry. 53: 12939-46. PMID 25415432 DOI: 10.1021/Ic502024A  0.103
2012 Li Y, Martin BR, Cravatt BF, Hofmann SL. DHHC5 protein palmitoylates flotillin-2 and is rapidly degraded on induction of neuronal differentiation in cultured cells. The Journal of Biological Chemistry. 287: 523-30. PMID 22081607 DOI: 10.1074/Jbc.M111.306183  0.102
2014 Jia L, Chisari M, Maktabi MH, Sobieski C, Zhou H, Konopko AM, Martin BR, Mennerick SJ, Blumer KJ. A mechanism regulating G protein-coupled receptor signaling that requires cycles of protein palmitoylation and depalmitoylation. The Journal of Biological Chemistry. 289: 6249-57. PMID 24385443 DOI: 10.1074/Jbc.M113.531475  0.097
1982 Voorheis HP, Martin BR. Local anaesthetics including benzyl alcohol activate the adenylate cyclase in Trypanosoma brucei by a calcium-dependent mechanism. European Journal of Biochemistry. 123: 371-6. PMID 6281006 DOI: 10.1111/j.1432-1033.1982.tb19778.x  0.096
1991 Sandy JR, Meikle MC, Martin BR, Farndale RW. Leukotriene B4 increases intracellular calcium concentration and phosphoinositide metabolism in mouse osteoblasts via cyclic adenosine 3',5'-monophosphate-independent pathways. Endocrinology. 129: 582-90. PMID 1713159 DOI: 10.1210/endo-129-2-582  0.096
2017 Won SJ, Eschweiler JD, Majmudar JD, Chong FS, Hwang SY, Ruotolo BT, Martin BR. Affinity-Based Selectivity Profiling of an In-Class Selective Competitive Inhibitor of Acyl Protein Thioesterase 2. Acs Medicinal Chemistry Letters. 8: 215-220. PMID 28197315 DOI: 10.1021/Acsmedchemlett.6B00441  0.096
2019 Motiwala HF, Kuo YH, Stinger BL, Palfey BA, Martin BR. Tunable heteroaromatic sulfones enhance in-cell cysteine profiling. Journal of the American Chemical Society. PMID 31881155 DOI: 10.1021/Jacs.9B08831  0.095
1981 Voorheis HP, Martin BR. Characteristics of the calcium-mediated mechanism activating adenylate cyclase in Trypanosoma brucei. European Journal of Biochemistry. 116: 471-7. PMID 6790278 DOI: 10.1111/j.1432-1033.1981.tb05360.x  0.095
2002 Adams SR, Campbell RE, Gross LA, Martin BR, Walkup GK, Yao Y, Llopis J, Tsien RY. New biarsenical ligands and tetracysteine motifs for protein labeling in vitro and in vivo: synthesis and biological applications. Journal of the American Chemical Society. 124: 6063-76. PMID 12022841 DOI: 10.1021/Ja017687N  0.094
1985 Heyworth CM, Whetton AD, Wong S, Martin B, Houslay M. Insulin inhibits the cholera-toxin-catalysed ribosylation of a Mr-25000 protein in rat liver plasma membranes. Biochemical Journal. 228: 593-603. PMID 3896232 DOI: 10.1042/Bj2280593  0.093
1988 Scimeca JA, Martin BR. The disposition of [3H]diisopropylfluorophosphate in guinea pigs after inhalation. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 16: 534-9. PMID 2903019  0.092
2007 Chen X, Che Y, Zhang L, Putman AH, Damaj I, Martin BR, Kendler KS, Miles MF. RhoA, encoding a Rho GTPase, is associated with smoking initiation. Genes, Brain, and Behavior. 6: 689-97. PMID 17284169 DOI: 10.1111/J.1601-183X.2006.00296.X  0.092
1987 Martin BR, Farndale RW, Wong SK. The role of Gs in activation of adenylate cyclase. Biochemical Society Transactions. 15: 19-21. PMID 3104109 DOI: 10.1042/Bst0150019  0.091
1973 Martin BR, Denton RM, Pask HT, Randle PJ. Mechanisms regulating adipose-tissue pyruvate dehydrogenase. The Biochemical Journal. 129: 763-73. PMID 4658997 DOI: 10.1042/bj1290763  0.091
2003 Polli JE, Kim S, Martin BR. Weight uniformity of split tablets required by a Veterans Affairs policy. Journal of Managed Care Pharmacy : Jmcp. 9: 401-7. PMID 14613437 DOI: 10.18553/Jmcp.2003.9.5.401  0.09
2013 Whisner CM, Martin BR, Schoterman MH, Nakatsu CH, McCabe LD, McCabe GP, Wastney ME, van den Heuvel EG, Weaver CM. Galacto-oligosaccharides increase calcium absorption and gut bifidobacteria in young girls: a double-blind cross-over trial. The British Journal of Nutrition. 110: 1292-303. PMID 23507173 DOI: 10.1017/S000711451300055X  0.089
1988 Martin BR, Morre DM. Excess vitamin A decreases the specific activity of galactosyltransferase in Golgi apparatus of rat liver Journal of Nutrition. 118: 968-975. PMID 2841439 DOI: 10.1093/Jn/118.8.968  0.089
1974 Prange AJ, Breese GR, Cott JM, Martin BR, Cooper BR, Wilson IC, Plotnikoff NP. Thydrotropin releasing hormone: antagonism of pentobarbital in rodents. Life Sciences. 14: 447-55. PMID 4207373 DOI: 10.1016/0024-3205(74)90359-2  0.089
1994 Mansbach RS, Nicholson KL, Martin BR, Balster RL. Failure of Delta(9)-tetrahydrocannabinol and CP 55,940 to maintain intravenous self-administration under a fixed-interval schedule in rhesus monkeys. Behavioural Pharmacology. 5: 219-225. PMID 11224271  0.089
1972 Coore HG, Denton RM, Martin BR, Randle PJ. Regulation of adipose tissue pyruvate dehydrogenase by insulin and other hormones. The Biochemical Journal. 125: 115-27. PMID 5158898 DOI: 10.1042/bj1250115  0.088
2009 Martin BR, Cravatt BF. Large-scale profiling of protein palmitoylation in mammalian cells. Nature Methods. 6: 135-8. PMID 19137006 DOI: 10.1038/Nmeth.1293  0.088
2007 Martin BR, Deerinck TJ, Ellisman MH, Taylor SS, Tsien RY. Isoform-specific PKA dynamics revealed by dye-triggered aggregation and DAKAP1alpha-mediated localization in living cells. Chemistry & Biology. 14: 1031-42. PMID 17884635 DOI: 10.1016/J.Chembiol.2007.07.017  0.088
2011 Lim J, Albright TA, Martin BR, Miljani? OŠ. Benzobisoxazole cruciforms: heterocyclic fluorophores with spatially separated frontier molecular orbitals. The Journal of Organic Chemistry. 76: 10207-19. PMID 22077919 DOI: 10.1021/Jo202107W  0.087
1976 Martin BR, Harvey DJ, Paton WDM. Identification of new in vivo side chain acid metabolites of Δ1 tetrahydrocannabinol Journal of Pharmacy and Pharmacology. 28: 773-774. PMID 10374 DOI: 10.1111/j.2042-7158.1976.tb04047.x  0.087
2013 Cobb MS, Rose FF, Rindt H, Glascock JJ, Shababi M, Miller MR, Osman EY, Yen PF, Garcia ML, Martin BR, Wetz MJ, Mazzasette C, Feng Z, Ko CP, Lorson CL. Development and characterization of an SMN2-based intermediate mouse model of Spinal Muscular Atrophy. Human Molecular Genetics. 22: 1843-55. PMID 23390132 DOI: 10.1093/Hmg/Ddt037  0.087
2007 Cheong JM, Martin BR, Jackson GS, Elmore D, McCabe GP, Nolan JR, Barnes S, Peacock M, Weaver CM. Soy isoflavones do not affect bone resorption in postmenopausal women: a dose-response study using a novel approach with 41Ca. The Journal of Clinical Endocrinology and Metabolism. 92: 577-82. PMID 17148567 DOI: 10.1210/Jc.2006-0369  0.086
2005 Zhao Y, Martin BR, Wastney ME, Schollum L, Weaver CM. Acute versus chronic effects of whey proteins on calcium absorption in growing rats. Experimental Biology and Medicine (Maywood, N.J.). 230: 536-42. PMID 16118403 DOI: 10.1177/153537020523000804  0.086
1994 Fan F, Compton DR, Ward S, Melvin L, Martin BR. Development of cross-tolerance between delta 9-tetrahydrocannabinol, CP 55,940 and WIN 55,212. The Journal of Pharmacology and Experimental Therapeutics. 271: 1383-90. PMID 7996450  0.085
2017 ElAzzouny M, Tom CT, Evans CR, Olson LL, Tanga MJ, Gallagher KA, Martin BR, Burant CF. Dimethyl itaconate is not metabolized into itaconate intracellularly. The Journal of Biological Chemistry. PMID 28188288 DOI: 10.1074/Jbc.C117.775270  0.085
1977 Martin BR, Houslay MD, Kennedy EL. Cholera toxin requires oxidized nicotinamide adenine dinucleotide to activate adenylate cyclase in purified rat liver plasma membranes Biochemical Journal. 161: 639-642. PMID 192202  0.084
2004 Martin BR, Dorhout PK. Molten flux synthesis of an analogous series of layered alkali samarium selenogermanate compounds. Inorganic Chemistry. 43: 385-91. PMID 14704091 DOI: 10.1021/Ic034724Y  0.084
2016 Majmudar JD, Konopko AM, Labby KJ, Tom CT, Crellin JE, Prakash A, Martin BR. Harnessing redox cross-reactivity to profile distinct cysteine modifications. Journal of the American Chemical Society. PMID 26780921 DOI: 10.1021/Jacs.5B06806  0.083
1990 Little PJ, Martin BR. Cannabinoid modulation of cyclic AMP accumulation in synaptosomes. Nida Research Monograph. 95: 282-3. PMID 2561832  0.083
2013 Davda D, El Azzouny MA, Tom CT, Hernandez JL, Majmudar JD, Kennedy RT, Martin BR. Profiling targets of the irreversible palmitoylation inhibitor 2-bromopalmitate. Acs Chemical Biology. 8: 1912-7. PMID 23844586 DOI: 10.1021/Cb400380S  0.083
1989 Savage AL, Biffen M, Martin BR. Vasopressin-stimulated Ca2+ influx in rat hepatocytes is inhibited in high-K+ medium. The Biochemical Journal. 260: 821-7. PMID 2548488 DOI: 10.1042/bj2600821  0.082
2017 Kuo YH, Konopko AM, Borotto NB, Majmudar JD, Haynes SE, Martin BR. Profiling protein S-sulfination with maleimide-linked probes. Chembiochem : a European Journal of Chemical Biology. PMID 28809078 DOI: 10.1002/Cbic.201700137  0.082
2013 Tom CT, Martin BR. Fat chance! Getting a grip on a slippery modification. Acs Chemical Biology. 8: 46-57. PMID 23215442 DOI: 10.1021/Cb300607E  0.081
2006 Marciano-Cabral F, Raborn ES, Martin BR, Cabral GA. Delta-9-tetrahydrocannabinol, the major psychoactive component in marijuana, inhibits macrophage chemotaxis to Acanthamoeba. The Journal of Eukaryotic Microbiology. 53: S15-7. PMID 17169039 DOI: 10.1111/J.1550-7408.2006.00158.X  0.081
2010 Martin BR, Braun MM, Wigertz K, Bryant R, Zhao Y, Lee W, Kempa-Steczko A, Weaver CM. Fructo-oligosaccharides and calcium absorption and retention in adolescent girls. Journal of the American College of Nutrition. 29: 382-6. PMID 21041813 DOI: 10.1080/07315724.2010.10719855  0.081
2012 Legette LL, Lee W, Martin BR, Story JA, Campbell JK, Weaver CM. Prebiotics enhance magnesium absorption and inulin-based fibers exert chronic effects on calcium utilization in a postmenopausal rodent model. Journal of Food Science. 77: H88-94. PMID 22394255 DOI: 10.1111/J.1750-3841.2011.02612.X  0.081
2011 Weaver CM, Martin BR, Nakatsu CH, Armstrong AP, Clavijo A, McCabe LD, McCabe GP, Duignan S, Schoterman MH, van den Heuvel EG. Galactooligosaccharides improve mineral absorption and bone properties in growing rats through gut fermentation. Journal of Agricultural and Food Chemistry. 59: 6501-10. PMID 21553845 DOI: 10.1021/Jf2009777  0.081
2016 Macdonald-Clarke CJ, Martin BR, McCabe LD, McCabe GP, Lachcik PJ, Wastney M, Weaver CM. Bioavailability of potassium from potatoes and potassium gluconate: a randomized dose response trial. The American Journal of Clinical Nutrition. PMID 27413123 DOI: 10.3945/Ajcn.115.127225  0.078
1989 Thomas BF, Martin BR. Identification of metabolites of CP-55,940 formed in-vitro by mouse livers. Nida Research Monograph. 95: 287-8. PMID 2640971  0.077
1977 Harvey DJ, Martin BR, Paton WDM. Identification of metabolites of Δ(1) and Δ(1(6)) tetrahydrocannabinol containing a reduced double bond Journal of Pharmacy and Pharmacology. 29: 495-497. PMID 19600 DOI: 10.1111/j.2042-7158.1977.tb11376.x  0.076
2018 Won SJ, Martin BR. Temporal profiling establishes a dynamic S-palmitoylation cycle. Acs Chemical Biology. PMID 29733200 DOI: 10.1021/Acschembio.8B00157  0.076
1973 Stuart BP, Martin BR, Williams LP, Von Byern H. Salmonella-induced meningoencephalitis in a foal. Journal of the American Veterinary Medical Association. 162: 211-3. PMID 4566997  0.076
2012 Getz KD, Janulewicz PA, Rowe S, Weinberg JM, Winter MR, Martin BR, Vieira VM, White RF, Aschengrau A. Prenatal and early childhood exposure to tetrachloroethylene and adult vision. Environmental Health Perspectives. 120: 1327-32. PMID 22784657 DOI: 10.1289/Ehp.1103996  0.074
1997 Owen TJ, Lantz GC, Hiles MC, VanVleet J, Martin BR, Geddes LA. Calcification potential of small intestinal submucosa in a rat subcutaneous model. The Journal of Surgical Research. 71: 179-86. PMID 9299288 DOI: 10.1006/jsre.1997.5148  0.074
1977 Clausen T, Martin BR. The effect of insulin on the washout of [45Ca]calcium from adipocytes and soleus muscle of the rat. The Biochemical Journal. 164: 251-5. PMID 880231 DOI: 10.1042/bj1640251  0.074
1975 Rodbell M, Lin MC, Salomon Y, Londos C, Harwood JP, Martin BR, Rendell M, Berman M. Role of adenine and guanine nucleotides in the activity and response of adenylate cyclase systems to hormones: evidence for multisite transition states. Advances in Cyclic Nucleotide Research. 5: 3-29. PMID 236641  0.073
1974 Rodbell M, Lin MC, Salomon Y, Londos C, Harwood JP, Martin BR, Rendell M, Berman M. The role of adenine and guanine nucleotides in the activity and response of adenylate cyclase systems to hormones: evidence for multi-site transition states. Acta Endocrinologica. Supplementum. 191: 11-37. PMID 4375375 DOI: 10.1530/Acta.0.077S0011  0.073
2014 Nakatsu CH, Armstrong A, Clavijo AP, Martin BR, Barnes S, Weaver CM. Fecal bacterial community changes associated with isoflavone metabolites in postmenopausal women after soy bar consumption. Plos One. 9: e108924. PMID 25271941 DOI: 10.1371/Journal.Pone.0108924  0.073
1991 Martin BR, Boni J. Pyrolysis and inhalation studies with phencyclidine and cocaine. Nida Research Monograph. 99: 141-58. PMID 2267010  0.072
2013 McKee AC, Stern RA, Nowinski CJ, Stein TD, Alvarez VE, Daneshvar DH, Lee HS, Wojtowicz SM, Hall G, Baugh CM, Riley DO, Kubilus CA, Cormier KA, Jacobs MA, Martin BR, et al. The spectrum of disease in chronic traumatic encephalopathy. Brain : a Journal of Neurology. 136: 43-64. PMID 23208308 DOI: 10.1093/Brain/Aws307  0.071
2015 Mez J, Solomon TM, Daneshvar DH, Murphy L, Kiernan PT, Montenigro PH, Kriegel J, Abdolmohammadi B, Fry B, Babcock KJ, Adams JW, Bourlas AP, Papadopoulos Z, McHale L, Ardaugh BM, ... Martin BR, et al. Assessing clinicopathological correlation in chronic traumatic encephalopathy: rationale and methods for the UNITE study. Alzheimer's Research & Therapy. 7: 62. PMID 26455775 DOI: 10.1186/S13195-015-0148-8  0.071
1972 Martin BR, Denton RM. Metabolism of pyruvate and malate by isolated fat-cell mitochondria. The Biochemical Journal. 125: 105-13. PMID 5158897 DOI: 10.1042/bj1250105  0.071
2014 Majmudar JD, Martin BR. Strategies for profiling native S-nitrosylation. Biopolymers. 101: 173-9. PMID 23828013 DOI: 10.1002/Bip.22342  0.071
2015 Yu J, Xiang L, Martin BR, Clearfield A, Sun L. Direct growth of layered intercalation compounds via single step one-pot in situ synthesis. Chemical Communications (Cambridge, England). 51: 11398-400. PMID 26086794 DOI: 10.1039/C5Cc03589A  0.07
2013 Martin BR. Nonradioactive analysis of dynamic protein palmitoylation. Current Protocols in Protein Science / Editorial Board, John E. Coligan ... [Et Al.]. 73: Unit 14.15. PMID 24510591 DOI: 10.1002/0471140864.Ps1415S73  0.07
2012 Lim J, Osowska K, Armitage JA, Martin BR, Miljani? OS. Critical role of weak [C-H⋯O] hydrogen bonds in the assembly of benzo[1,2-d:4,5-d′]bisoxazole cruciforms into supramolecular sheets Crystengcomm. 14: 6152-6162. DOI: 10.1039/C2Ce25485A  0.07
Hide low-probability matches.